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Zusammenfassung
���������� ���������� verursacht die schlimmste Form der menschlichen Malaria und ist
verantwortlich für 1-2 Millionen Todesfälle jährlich. Ein Impfstoff ist nicht vorhanden, und
Resistenz gegen Medikamente ist weit verbreitet. Die Identifizierung neuer Interventionsziele
für die medikamentöse Behandlung wäre eine Möglichkeit, diese Probleme anzugehen. Dieser
Ansatz wird jedoch durch ein limitiertes Verständnis vieler Aspekte der �� ����������-
Biologie behindert.
Morbidität und Mortalität zufolge Malaria werden durch die asexuellen Stadien des Erregers
in den menschlichen roten Blutkörperchen (RB) verursacht. Während die meisten
intrazellulären Parasiten mit aktiven Wirtszellen interagieren, entwickelt sich der Malaria-
Erreger in einer terminal differentierten Zelle ohne Organellen und ohne
Transportmaschinerie für Proteine. Der Parasit residiert in einer parasitophoren Vakuole (PV),
die von einer parasitophoren Vakuolenmembran (PVM) umgeben ist. Der Parasit modifiziert
die Wirtszelle durch Errichtung von membranösen Strukturen im Zytosol des RB. Diese
Modifikationen beinhalten unter anderem diskoide Strukturen mit unbekannter Funktion in
der Peripherie des RB, genannt „Maurer’s clefts“ (MC). Zusätzlich verändert der Parasit die
Wirtszelle durch den Export von eigenen Proteinen an die Oberfläche der des RB. Diese
Exportprodukte tragen massgeblich zur Virulenz des Parasiten bei, wobei das variante
Oberflächen-Antigen „���������� ���������� erythrocyte membrane protein 1“ (PfEMP1)
ein Hauptakteur ist, der die Adhärenz von infizierten Erythrozyten an die Endothelzellen
bewirkt und dadurch, so vermutet man, die Eliminierung des infizierten RB durch die Milz
verhindert. Der Parasit entgeht dem Immunsystem zusätzlich durch Antigenvariation, d.h.
durch die wechselnde Expression verschiedener Mitglieder der PfEMP1-Proteinfamilie.
Da reife RB keine zelluläre Transportmaschinerie mehr haben, etabliert der Parasit sein
eigenes Sekretionssystem, um Proteine über die Parasitenmembran (PM) hinaus durch die
PVM und durch das Erythrozytenzytosol hindurch zu den MCs und der Wirtszellenmembran
zu exportieren. Die Mechanismen und molekularen Komponenten, welche an diesem Prozess
beteiligt sind, sind noch nicht vollständig geklärt. Eine klassische Signalsequenz ist
ausreichend, um Proteine in das endoplasmatische Retikulum (ER) zu lenken mit
vorgegebener Weiterleitung in die PV. Weitertransport durch die PVM benötigt eine
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zusätzliche Signalsequenz, genannt „���������� Export Element“ (PEXEL) oder „Vacuolar
Targeting Signal“ (VTS).
Ziel dieser Arbeit war die Charakterisierung eines neuen Transmembran (TM)-Proteins, des
sogenannten „membrane associated histidine-rich protein 1“ (MAHRP1). Es wird
ausschliesslich in jungen Stadien transkribiert, hat eine C-Domäne mit rund 30% aus DHGH-
Wiederholungen bestehenden Histidinen und ist an den Maurer’s Clefts lokalisiert. MAHRP1
hat keine klassische Signalsequenz und keine PEXEL/VTS-Signale, und es ist somit unklar,
wie das Protein zu den MCs gelangt.
Histidinreiche Proteine sind bekannt als gute Kationen-Binder. Der histidinreiche Teil von
MAHRP1 wurde rekombinant exprimiert und verwendet für Interaktionsstudien mit
Ferriprotoporphyrin (FP), einem toxischen Abfallprodukt, welches bei der Zersetzung von
Hämoglobin anfällt, einer Hauptnahrungsquelle des Parasiten. MAHRP1 interagiert spezifisch
mit FP und die Bindungsstöchiometrie korreliert mit der Anzahl vorhandener DHGH-
Wiederholungen. Gebundenes FP weist eine erhöhte Peroxidase-ähnliche Aktivität auf, und
seine Anfälligkeit für H202-induzierte Degradation ist zehnmal höher als diejenige von
ungebundenem FP. Diese Eigenschaften von MAHRP1 lassen vermuten, dass es bei den
MCs eine protektive Rolle gegen oxidative Belastung spielt.
Für die Untersuchung der Aminosäuren, die für den korrekten Transport von MAHRP1
zustaendig sind, wurden Plasmide generiert, welche verschiedene MAHRP1-Domänen
enthalten, die an grün fluoreszierendes Protein (GFP) gekoppelt sind. Parasiten wurden
anschliessend mit diesen Plasmiden transfiziert. Analysen der verschiedenen Transfektanten
ergaben, dass das ganze MAHRP1-GFP erfolgreich an die MCs gelangt, hingegen die TM-
oder TM-C-Domänen im ER zurückgehalten werden. Weitere Zergliederungen der N-
Domäne deckten eine 18 Aminosäuren grosse Region auf, welche ein Signal mit limitierter
Aehnlichkeit zum PEXEL/VTS-Signal aufweist und welche notwendig ist für den Export von
MAHRP1 zu den MCs. „Fluorescence recovery after photobleaching“ (FRAP) und
Zeitreihenphotographie-Anwendungen weisen darauf hin, dass MAHRP1-GFP zuerst zu
isolierten Subdomänen der PV/PVM transportiert wird, die entstehende MCs darzustellen
scheinen. Die gewonnenen Daten lassen vermuten, dass die MCs in der PVM knospen,
anschliessend durchs Zytosol der RB diffundieren und sich schliesslich an der Zellperipherie
ansiedeln.
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Zur weiteren Klärung der Funktion von MAHRP1 wurde eine Mutante mit einer ������
Disruption und einer MAHRP1 Ablation generiert. MCs werden auch in Abwesenheit von
MAHRP1 immer noch gebildet, aber der Export von PfEMP1 wird im PV/PVM-Bereich
angehalten. Dementsprechend ist kein PfEMP1 an der Wirtszellen-Oberfläche zu finden. Der
Export von anderen ausgewählten Proteinen scheint jedoch unverändert zu funktionieren.
Dies deutet darauf hin, dass MAHRP1 eine essentielle Rolle beim Export des bedeutenden
Virulenzfaktors PfEMP1 spielt und somit ein attraktives Interventionsziel im Kampf gegen
Malaria darstellt.
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Summary
���������� ���������� causes the worst form of human malaria and is responsible for 1-2
million deaths annually. A vaccine is not available and resistance to drugs is widespread. One
approach to tackle these problems is to identify new intervention targets. However, this is
hampered by a limited understanding of many aspects of �� ���������� biology.
The morbidity and mortality associated with malaria is due to the asexual erythrocyte stages
of �� ����������. While most intracellular pathogens interact with an active host cell, the
malaria parasite develops within the red blood cell (RBC) that is devoid of all organelles and
any protein trafficking machinery. The parasite resides in a parasitophorous vacuole (PV),
which is encircled by a parasitophorous vacuolar membrane (PVM). The parasite modifies its
host cell by establishing membranous structures in the RBC cytoplasm. These comprise disc-
shaped structures at the RBC periphery called Maurer’s clefts (MC) with an elusive function.
In addition the parasite modifies the surface of the infected RBC by exporting own proteins
that contribute to the virulence of �� ����������. A key protein in this process is the variant
surface antigen, �� ���������� erythrocyte membrane protein 1 (PfEMP1), which mediates
adherence of infected RBCs to host endothelial cells. This is thought to prevent the infected
RBC of being cleared by the spleen. Furthermore the parasite evades the immune system by a
process called antigenic variation, the switching of the expression between different members
of PfEMP1.
As mature RBCs lack a cellular trafficking machinery, the parasite establishes its own
secretory system for exporting proteins beyond the parasite membrane (PM) through the PVM
and across the host cell cytoplasm to the MCs and the RBC membrane. The mechanisms and
molecular apparatus involved in this process are not completely understood. A classical signal
sequence is sufficient to direct proteins into the endoplasmatic reticulum (ER) with default
release into the PV. Onward transport across the PVM requires an additional signature termed
���������� export element (PEXEL) or vacuolar targeting signal (VTS).
The aim of this thesis was to characterize a novel transmembrane (TM) protein termed
membrane-associated histidine-rich protein 1 (MAHRP1). It is transcribed exclusively in
early stages, has a C-terminus with approximately 30% histidines present as DHGH repeats
and localizes to the Maurer’s clefts. MAHRP1 has no classical signal sequence and no
PEXEL/VTS motif and it is thus unclear how it is directed to the MCs.
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Histidine-rich proteins have been shown to be effective cation binders. The histidine-rich
region of MAHRP1 was recombinantly expressed and used for interaction studies with the
toxic waste product ferriprotoporphyrine (FP), which accumulates upon degradation of
hemoglobin -a main nutrient source of the parasite. MAHRP1 specifically interacts with FP
and binding stoichiometry correlates with the amount of DHGH repeats. The bound FP has
increased peroxidase-like activity and is 10-fold more susceptible to H2O2-induced
degradation compared with unbound FP. These properties of MAHRP1 suggest it may play a
protective role against oxidative stress at the MCs.
To investigate the amino acids responsible for correct trafficking of MAHRP1 to the MCs,
plasmids were generated encoding different green fluorescent protein (GFP)-tagged domains
of MAHRP1 and parasites were subsequently transfected with these plasmids. Analysis of
transfectants showed that the full length MAHRP1-GFP is successfully trafficked to the MCs,
whereas the domains TM or TM-C-terminus were retained at the ER. Dissection of the N-
terminus revealed a segment of 18 amino acids containing a motif with limited similarity to
the PEXEL/VTS motif, and which is needed for export of MAHRP1 to the MCs.
Fluorescence photobleaching and time-lapse imaging techniques indicate that MAHRP1-GFP
is initially trafficked to isolated subdomains in the PV/PVM that appear to represent nascent
MCs. The data suggest that the MCs bud from the PVM and diffuse within the RBC
cytoplasm before taking up residence at the cell periphery.
To understand the function of MAHRP1, a mutant with a ������ disruption and MAHRP1
ablation was generated. MCs are still formed in the absence of MAHRP1 but the export of
PfEMP1 is interrupted at the PM/PVM interface. As a consequence, no PfEMP1 is detected
on the surface of infected RBCs. By contrast, export of other selected proteins appears to be
uninhibited. This indicates that MAHRP1 plays an essential role in the export of major
virulence factor PfEMP1 and thus represents an interesting intervention target in the battle
against malaria.
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�������������
EBA erythrocyte-binding antigen
EM electron microscopy
ER endoplasmatic reticulum
ETRAMP early transcribed membrane protein
EXP1 exported protein 1
FP ferriprotoporphyrine
FRAP fluorescence recovery after photobleaching
FV food vacuole
GFP green fluorescent protein
HPI hours post invasion
HRP histidine-rich protein
HRP2 histidine-rich protein 2
HTS host targeting signal, used equivalent of VTS
IC50 half maximal inhibitory concentration
iRBC infected red blood cell
KAHRP knob-associated histidine-rich protein
MAHRP1 membrane-associated histidine-rich protein 1
MC Maurer’s clefts
PEXEL ���������� export element
PfEMP1 ���������� ���������� erythrocyte membrane protein 1 1
PM parasite membrane
PV parasitophorous vacuole
PVM parasitophorous vacuolar membrane
RBC red blood cell
RBCM red blood cell membrane
REX1 ring expressed protein 1
SBP1 skeleton binding protein 1
TVN tubovesicular network
VTS vacuolar targeting signal, used equivalent of HTS
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Introduction
Malaria is caused by protozoans of the genus ����������. It belongs to the phylum of the
����������� that contains other human and animal pathogens such as ����������,
���������������, �������, ������� and ���������. ����������� are characterized by the
presence of an apical complex in juxtaposition to the nucleus. The genus ����������
contains more than 100 species of which four infect humans: ���������� ����������, the
most important pathogen for humans, �� �����, �� �����, and �� ��������. Other species that
infect monkeys (eg. �� ��������, �� ���������) or rodents (�� ������, �� �������, �� ��������,
�� �������) are studied and used as animal models.
Today approximately 40% of the world’s population, mostly living in the world’s poorest
countries, is at risk of malaria. Each year, 300-500 million people become infected and 1 to 2
million will die (WHO, 2005). Clinical manifestations of severe malaria include cerebral
malaria, severe anaemia, hypoglycaemia, renal failure, non-cardiac pulmonary oedema, and
respiratory failure (WHO, 2000). Once in the blood, the processes associated with the
multiplication of the parasite in the red blood cells (RBCs) are responsible for most of the
clinical symptoms of malaria and its associated morbidity and mortality.
No vaccine is available and resistance to most antimalarial drugs occurs in many parts of the
world. Research is mainly focussing on �� ���������� because of its clinical importance. In
addition, an �� ����� culturing system is available (Trager and Jensen, 1976) and the genome
has been sequenced for the culture strain 3D7 (www.plasmodb.org).The nuclear genome of ��
���������� (3D7) contains 22.8 million base pairs distributed on 14 chromosomes (Gardner
et al., 2002). About 5300 coding genes have been identified of which more than 60% have no
assigned function as they lack homology to any known protein based on their primary
sequence.
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1.1 ���������� ���������� life cycle
���������� ���������� maintains a complex life cycle. It alternates between the vertebrate
human host and the invertebrate female mosquito of the genus ��������� (several species).
The cycle begins when haploid sporozoites are injected into the human host by an infected
mosquito during a blood meal. Once in the bloodstream, sporozoites migrate to the liver
where they invade hepatocytes, multiply asexually and after 5-20 days release thousands of
merozoites into the blood stream. These now invade a second type of host cells, namely
human erythrocytes, where they undergo a 48 h cycle of asexual replication. Encompassed in
a parasitophorous vacuolar membrane (PVM), the parasites develop from ring stages or early
trophozoites (0–22 h post invasion [hpi]) to trophozoites (22–36 hpi) and finally to schizonts
(36–48 hpi). Rupture of schizonts releases up to 32 merozoites into the bloodstream, which
initiate a new round of schizogony. Some of the intraerythrocytic parasites develop into
sexual blood stages (gametocytes). These gametocytes must be taken up by an anopheline
mosquito during another blood meal. Once in the mosquito gut, gametocytes develop into
gametes and sexual reproduction takes place whereby 8 flagellated microgametes are released
from a male gametocyte fertilizing a female macrogamete to form a diploid zygote. The
zygote develops into an ookinete capable of penetrating the gut wall and maturing to an
oocyst in about 10 days. The oocyst finally ruptures to release a large number of haploid
sporozoites into the haemolymph. The sporozoites migrate to the salivary gland from where
they are injected into the human host during the next blood meal to complete the cycle.
1.2 Parasite cell biology
Our work focuses on specific molecular processes that take place in the intraerythrocytic part
of the �� ���������� life cycle. For this reason this chapter will focus on aspects of this part of
the parasite’s complex life cycle only. Figure 1 summarizes and exemplifies key points
described below.
Rapid growth of the parasite within the host erythrocyte is achieved, in part, by digesting
hemoglobin within a lysosome-like compartment that is referred to as the food vacuole (FV).
The food vacuole becomes evident at the transition between ring and subsequent trophozoite
stages (Francis et al., 1997). Hemoglobin proteolysis takes place by a series of parasite-
derived proteases. Digestion of hemoglobin by the parasite first requires the engulfment of
portions of host cytoplasm across the parasitophorous vacuole (PV) and the plasma membrane
Chapter 1. ���������� ���������� Biology
13
(PM) and into the FV. This process has been morphologically characterised and involves a
specialized endosome-like organelle, referred to as the cytostome. The molecular events
mediating this process, however, are completely unknown.
Approximately 35 hours after invasion, when most of the hemoglobin has been consumed, the
parasite initiates simultaneous synthesis of up to 32 daughter merozoites, each of which is
capable of invading a new red blood cell. As a part of merozoite formation, the apical
organelles comprising of the rhoptries, micronemes and dense granules are formed �� ���� by
the secretory pathway (Tonkin et al., 2006).
Micronemes are storage organelles for adhesive proteins such as members of the EBL-
family, EBA-175, EBA-140/BAEBL, and EBA-181/JSEBL (Sim et al., 1994; Thompson et
al., 2001; Gilberger et al., 2003). They release their contents onto the parasite surface upon
host cell recognition. Rhoptries are larger club-shaped organelles that are found at the apex
of the polarized merozoite. They are approximately 400 nm long (Bannister, 2001) and they
contribute to the invasion process as well as to the synthesis of the PV (Kats et al., 2006). The
third set of apical organelles are dense, rounded vesicles termed dense granules which
probably expel their contents into the PV upon entry into the host cell and may contribute to
the expansion of the PVM and also cause other modifications of the RBC.
As a member of the Apicomplexans, �� ���������� contains a plastid called the apicoplast
that is essential for parasite survival. The apicoplast is surrounded by four membranes and is a
remnant of a secondary endosymbiontic event. It allows the parasite to synthesize various
vitamins and aromatic precursor molecules �� ���� which cannot be obtained from its host
(Kohler et al., 1997; Roos et al., 2002; Waller et al., 2003).
Little is known about the molecular organization of the secretory pathway of �� ����������.
The endoplasmatic reticulum (ER) resembles a simple perinuclear structure with two
protruding ‘horns’, and several eukaryotic ER homologues have been found, such as the
endoplasmic reticulum calcium-binding protein (La Greca et al., 1997) and a homologue of
the heat shock protein 70 (Bianco et al., 1986). A typically stacked Golgi apparatus has not
been identified in the parasite, but a discoid cisterna close to the nucleus has been described
that was provisionally specified as a minimal Golgi apparatus (Bannister et al., 2000;
Bannister et al., 2003; Struck et al., 2005). Different Golgi homologues have been localized in
perinuclear area such as the GTPase Rab6 (Van Wye et al., 1996), the KDEL receptor
(Elmendorf and Haldar, 1993b) and the Golgi re-assembly stacking protein GRASP (Struck et
al., 2005).
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Electron microscopy (EM) studies have identified a single mitochondrion as a crescent-
shaped organelle in merozoites, which branches out in trophozoites, before segregating along
with the nucleus into daughter merozoites (Slomianny and Prensier, 1986; Akompong et al.,
2002; van Dooren et al., 2005). Interestingly, EM studies revealed a close association between
the apicoplast and the mitochondrion at various stages during the intraerythrocytic cycle
(Hopkins et al., 1999). This mitochondrion/apicoplast association has been postulated to occur
to allow transfer of metabolites between the two organelles (Hopkins et al., 1999; Ralph et al.,
2004).
Figure 1. Schematic representation of a ���������� ����������-infected red blood cell.
Selected proteins are shown at their final destinations.
Abbreviations: RBCM, red blood cell membrane; PVM, parasitophorous vacuolar membrane;
PM, parasite membrane; TVN, tubovesicular network; N, nucleus; ER, endoplasmatic
reticulum, G, Golgi apparatus; R, rhoptries; DG, dense granules, M, micronemes; FV, food
vacuole; A, apicoplast; M, mitochondrion; C, cytostome; NPP, new permeation pathways.
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1.3 Refurbishing the host cell
Human erythrocytes are highly specialized cells, denucleated, devoid of internal organelles,
lacking a full repertoire of nutrient transporters and a functional protein trafficking system,
and also lacking major histocompatibility complex (MHC) molecules. This metabolically
inert cell allows the parasite to hide from the immune system. As a trade-off, the parasite
needs to refurbish the host cell to import nutrients, dispose of waste products, and export
proteins across its plasma membrane (PM), the surrounding PVM, the erythrocyte cytosol and
red blood cell membrane (RBCM). The parasite radically modifies the properties of its host
cell. A few are listed in the following:
� A tubovesicular network (TVN) extends from the PVM into the cytoplasm of
trophozoite infected RBCs. This network harbours the Golgi marker sphingomyelin
synthase and was therefore thought to possess secretory properties (Elmendorf and
Haldar, 1993a). However, other results provide evidence for involvement of the TVN
in nutrient import that may happen at a TVN-RBC membrane junction (Lauer et al.,
1997).
� New permeation pathways are established at 15 hpi in the host cell membrane
(Staines et al., 2001), and several parasite proteins become associated with the RBC
cytoskeleton (Cooke et al., 2001). However, not only parasite proteins are suspected to
be the molecular basis for these new permeation pathways. There is evidence that
parasite-induced membrane oxidation is also responsible for activation of an
endogenous RBC membrane channel (Huber et al., 2002). Appearance of these
modifications at the late ring to early trophozoite stage coincides with onset of rapid
parasite growth and sequestration in postcapillary venules.
� Flattened vesicular structures called Maurer’s clefts (MC) are parasite-derived
structures positioned in the red blood cell cytosol. Maurer’s clefts are characterized as
flattened lamellar, slender membrane structures with a translucent lumen and an
electron-dense coat (Langreth et al., 1978; Atkinson et al., 1988; Elford et al., 1997;
Kriek et al., 2003). These compartments appear near the parasitophorous vacuole, but
they gradually relocate closer to the RBC membrane and appear to be tethered by
fibrous connections to the RBC membrane skeleton (Atkinson and Aikawa, 1990;
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Waterkeyn et al., 2000). There is currently some debate as to whether the Maurer’s
clefts are independent structures, or sub-domains of the tubovesicular network. A
recent study used serial electron micrograph sections to examine these structures in the
�� ���������� iRBC cytosol (Wickert et al., 2004). These authors postulate that
Maurer’s clefts and the tubovesicular network form part of a continuous meshwork.
Other reports analysed the dynamics of GFP chimeras of Maurer’s cleft–associated
cargo and suggest that Maurer’s clefts are distinct entities (Wickham et al., 2001;
Knuepfer et al., 2005; Spycher et al., 2006).
To present it is not fully understood what the role of the Maurer’s clefts is and
different functions have been proposed. Two independent studies have localized the
hypoxanthine phosphorybosyl transferase to the MCs (Shahabuddin et al., 1992;
Vincensini et al., 2005). In addition, a fatty acyl-Co synthase 1 (Matesanz et al., 1999)
and a phosphoethanolamin-N-methyl transferase (Vincensini et al., 2005) have been
proposed to be MC-associated. These findings suggest that Maurer’s clefts house
metabolic enzymes. Other studies have identified several kinases including ��
���������� exported serine-threonine kinase (FEST ,Kun et al., 1997), �� ����������
calcium-dependent protein kinase 1 (PfCDPK1, Moskes et al., 2004) and ��
���������� glycogen synthase kinase 3 ortholog (PfGSK3, Droucheau et al., 2004) to
be at MCs and thus suggest them to act as a signalling platform. The most frequently
discussed hypothesis suggests that Maurer’s clefts are in some way involved in
transport of parasite proteins to the RBC plasma membrane (Barnwell, 1990). The fact
that most of the parasite-derived surface-exposed proteins are trafficked via Maurer’s
clefts, independent of their solubility, underlines this hypothesis. In addition, ��
���������� homologs of proteins involved in vesicle transport such as Pfsec23 and
Pfsec31 (Albano et al., 1999; Adisa et al., 2001) have been localized to the MCs.
Furthermore, Maurer’s clefts have been shown to be involved in transport and
possibly the assembly of proteins forming knobs (Wickham et al., 2001), and a
Maurer’s clefts resident, skeleton-binding protein-1 has been shown to be essential for
the export of the major virulence factor �. ���������� erythrocyte membrane protein 1
(PfEMP1) to the RBC surface (Cooke et al., 2006).
Bringing together the different ideas on connectivity of MCs with the suggested
functional involvement of Maurer’s clefts as a “secretory” compartment has led to 4
different models as exemplified in figure 2 below.
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Figure 2. Putative protein trafficking pathways from the parasite (in green) to the
erythrocyte plasma membrane (in red). (A) Giant vesicle. Parasite proteins are transported
by a conglomerate of Maurer’s clefts membranes that pinch off the parasitophorous vacuolar
membrane (PVM) and finally fuse with the host cell plasma membrane. (B) Vesicular
transport model. Parasite proteins are transported by small vesicles that bud off the PVM
and fuse with Maurer’s clefts residing as isolated entities within the cytosol of the infected red
blood cell. In a second step, target vesicles bud off from the Maurer’s clefts to fuse with the
plasma membrane of the infected erythrocyte. (C) Lateral diffusion model. Proteins of
parasite origin are routed by an interconnected Maurer’s cleft membrane network bridging the
distance between the PVM and the plasma membrane of the infected red blood cell. Small
vesicles pinch off at the very edges of the Maurer’s cleft membrane network just beneath the
membrane of the infected red blood cell, thereby shuttling parasitic proteins to the cell
surface. (D) Lateral diffusion model without vesicles. In this model, parasitic proteins are
transported by lateral diffusion from the PVM to the surface of the infected erythrocyte along
the Maurer’s cleft membrane network without the need of small vesicles. Instead, local fusion
of Maurer’s cleft membranes with the plasma membrane of the erythrocyte would allow
proteins to reach the surface (Lanzer et al., 2006).
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1.4 Early events upon invasion
To date, little is known about the molecular events taking place in the earliest steps upon
invasion: the ring stage. Compared to later stage parasites, ring stages are characterized by
low metabolic and biosynthetic activity (Zolg et al., 1984; de Rojas and Wasserman, 1985),
and little change in size and morphology. However, it is unlikely that the parasite lies dormant
during half of its asexual development in RBCs, and it is assumed that this “lag”-phase serves
the parasite to induce the elaborate host cell modifications apparent in later stages and crucial
for establishment in the host cell. This initial host cell refurbishment is necessary for growth
and survival and must include a protein-trafficking system to deliver the required components
beyond the parasite’s boundaries into different locations of the host cell. Apart from the
intriguing cell biological aspects, this situation most probably demands unusual processes
essential for parasite survival. Deciphering these early events does not only contribute to the
understanding of this parasite’s “establishment strategies” but also represents an interesting
target for drug intervention.
To address the question of early events upon invasion, Spielmann and Beck have used
suppression subtractive hybridization to clone genes exclusively transcribed during the ��
���������� ring stage (Spielmann and Beck, 2000). In contrast to genes originating from a
trophozoite-specific library, few of the identified ring-specific genes showed homologies to
known genes of other organisms, which is in accordance with the unique nature of the
molecular events in early stages. One of these genes, �������� ������� ������� � (����� has
previously been shown to code for a protein located in Maurer’s clefts and was proposed to
bind the erythrocyte scaffold (Blisnick et al., 2000). Furthermore, their work identified three
members of a new gene family coding for highly charged putative membrane proteins
referred to as early transcribed membrane proteins (Spielmann and Beck, 2000). Among the
other ring stage-specific genes, two histidine-rich proteins were found. They were named
membrane-associated-histidine-rich protein 1 (Spycher et al., 2003) and 2 (MAHRP2,
unpublished). In an attempt to better understand early events upon invasion, we characterized
MAHRP1 and addressed the question of its locations and possible function. These findings
are summarized in Chapter 2.
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2. Histidine-rich proteins
Histidine is one of the 20 most common natural amino acids present in proteins. The
imidazole side chains and the relatively neutral pK of histidine (ca 6.0) mean that relatively
small shifts in cellular pH will change its charge. For this reason, this amino acid side chain
finds its way into considerable use as a co-ordinating ligand in metalloproteins, and also as a
catalytic site in certain enzymes.
There are numerous studies on histidine-rich proteins (HRPs) in prokaryotic and eukaryotic
organisms. Human saliva, for instance, contains a family of low molecular weight cationic,
histidine-rich polypeptides known as histatins. Reports describe their potent bactericidal and
fungicidal properties (MacKay et al., 1984; Pollock et al., 1984). These peptides form part of
the innate immune system and play an important role in maintaining oral health by limiting
infections in the oral cavity.
Histidine-rich glycoprotein (HRG) is found in the plasma of many vertebrates and has an
overall histidine content of 13%. Metal and heme binding to HRG is mediated via the
numerous histidine residues and it appears that the metal binding function of HRG is to
modify the conformation of the molecule and thereby regulate subsequent biological activities
such as the modulation of angiogenesis regulation of cell adhesion and migration (Jones et al.,
2005).
A third example is the histidine-rich protein Hpn in ����������� ������. The gram-negative
bacterium colonizes the stomach and causes gastritis and ulcerations. Its adaptation to this
hostile environment is linked to the production of abundant urease, a nickel containing
metalloenzyme catalyzing the hydrolysis of urea and carbamate for neutralization of gastric
acid, which is critical for survival under low pH conditions. Therefore, a constant supply of
nickel ions is required for the synthesis and activity of ureases by �� ������� Hpn has been
proposed to play a role in nickel storage (Ge et al., 2006).
In ����������, first publications on histidine-rich proteins date back to 1975. In the
meantime there is a small number of well characterized HRPs. HRPs seem to play a key role
in the parasite survival strategy. One day into the two-day intraerythrocytic cycle, parasites
begin to ingest the abundant hemoglobin of their host erythrocyte by an endocytic process.
The parasite degrades about 75% of the hemoglobin (Loria et al., 1999). The released amino
acids are incorporated into parasite proteins and also appear to be available for energy
metabolism. Proteolysis is thought to be essential for parasite survival because �� ����������
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has a limited capacity for �� ���� amino acid synthesis (Sherman, 1977). However, the
proteolytic degradation of hemoglobin also produces heme (ferriprotoporphyrin IX). Free
intracellular ferriprotoporphyrin (FP) is toxic due to its detergent-like (Chou and Fitch, 1981),
and redox properties (Tappel, 1953). The parasite appears to dispose of FP largely by
sequestration in the parasite’s food vacuole as a granular pigment known as hemozoin (�-
hematin (Slater and Cerami, 1992; Egan et al., 2002). It has been shown previously that this
crystallization process is initiated and accelerated �� ����� by parasite-derived histidine-rich
proteins (Sullivan et al., 1996; Papalexis et al., 2001), and the inhibition of hemozoin
formation is believed to underlie the mode of action of chloroquine �� ���� (Ziegler et al.,
2001). It has also been suggested that non-enzymatic degradation, including reactions with
H2O2 and glutathione may contribute to heme detoxification (Ginsburg et al., 1998; Loria et
al., 1999) and that histidine-rich proteins may modulate these processes (Ginsburg et al.,
1998). Several parasite-encoded histidine-rich proteins have been described, of which three
are discussed in more detail in the following:
� �� ���������� histidine-rich protein 2 (HRP2, MAL13P1.480) is one of the best
characterized. This soluble protein is found in the food vacuole but also in the
erythrocyte cytosol (Howard et al., 1986; Papalexis et al., 2001). Earlier studies
suggested that HRP2 is ingested by the parasite’s cytostome from the red cell together
with hemoglobin and thereby delivered to the food vacuole by bulk endocytosis
(Sullivan et al., 1996). However, recent studies show that although 75% of the
hemoglobin is ingested by the parasite, more than 90% of HRP2 remains in the
erythrocyte cytosol (Akompong et al., 2002). Cytosolic HRP2 seems to concentrate
mainly near the periphery of the erythrocyte, suggesting that it may not diffuse freely
through the erythrocyte cytoplasm and could thereby avoid its ingestion. These recent
findings suggest that HRP2 could play a role in the detoxification of the by-products
of hemoglobin degradation in the host cytoplasm. Recently, it has been shown that
HRP2 modulates the redox activity of FP and that the HRP2-FP complex may have
antioxidant properties (Mashima et al., 2002). Hence, the location of HRP2 near the
erythrocyte membrane may function to protect the host membrane from oxidative
stress and thus prevent premature host cell lysis.
HRP2 is nowadays an established marker in malaria rapid diagnostic tests such as
ParaSight�-F-Test (Becton Dickinson) and ICT MalariaPf� Test (ICT diagnostics,
reviewed in (Moody, 2002).
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� The �� ���������� knob-associated histidine-rich protein (KAHRP, PFB0100c) is
another well-characterized HRP. KAHRP is a soluble protein and essential for the
formation of knob-like protuberances on the surface of infected erythrocytes (Crabb et
al., 1997; Waller et al., 1999; Rug et al., 2006). KAHRP interacts with various
cytoskeletal components of the erythrocyte including spectrin, actin and actrin-
spectrin-band 4.1 complexes (Kilejian et al., 1991; Oh et al., 2000; Pei et al., 2005).
Knobs act as platforms for the presentation of �� ���������� erythrocyte membrane
protein-1 (Waller et al., 1999), which is responsible for adherence of parasitized
erythrocytes to vascular endothelial cells (Su et al., 1995). This adhesion and
subsequent accumulation of infected erythrocytes in the microvasculature are pivotal
events in the pathogenesis of �� ���������� malaria, and are considered to represent
major virulence mediators. It has been shown, that targeted ����� disruption leads to a
reduction of cytoadherence under shear stress (Crabb et al., 1997).
� The most recently discovered HRP in �� ���������� is the membrane-associated
histidine-rich protein 1 (MAHRP1, MAL13P1.413). We have characterized this
novel transmembrane protein, which is expressed in early stages upon invasion of
RBCs and localizes to the Maurer’s clefts (MCs). Unlike KAHRP and HRP2, it is not
a soluble protein and is thought to reside permanently in association with the Maurer’s
clefts. To elucidate if MAHRP1 plays a role in metal-binding and putative
“microprotection” of MCs from deleterious effects caused by free FP, we
recombinantly expressed the C-terminus, which consist of nearly 30% histidines, and
used it in binding studies with ferriprotoporphyrin FP IX. At the MCs, the histidine-
rich C-terminus is predicted to face the cytosolic side and this may point to a role in
local detoxification processes at the MCs. Findings were published and are shown and
discussed in chapter 2.
3. Cellular transport pathways
In eukaryotic cells, there are two main protein transport pathways. (I) The secretory
pathway, which is used to transport not only proteins that are secreted from the cell but also
resident proteins in the lumen of the endoplasmic reticulum, Golgi, and lysosomes as well as
integral proteins of the membrane of these organelles and the plasma membrane. (II) The
endocytic pathway, which transports ingested molecules in vesicles generated at the plasma
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membrane to early endosomes and then via late endosomes to lysosomes. Furthermore, there
are transport pathways directing proteins to mitochondria or chloroplasts, peroxisomes and
the nucleus.
Transport of proteins and lipids along the endocytic or secretory pathways is a hallmark of
eukaryotic cells. The secretory system allows cells to regulate delivery of newly synthesized
proteins, carbohydrates, and lipids to the cell surface - a necessity for growth and
homeostasis. Intracellular traffic is very selective. Only a subset of the proteins and lipids in
the donor membrane are given access into the transport vesicle, effectively preventing the
homogenization of membrane components and permitting membranous organelles to maintain
distinct identities throughout the life of the cell.
3.1 General features of the secretory pathway
All nuclear-encoded mRNAs are translated on cytosolic ribosomes. Nascent proteins destined
for the secretory pathway often contain an ER signal sequence, which directs them to the ER.
The protein therefore enters or crosses the ER membrane by translocation during its synthesis.
At the ER exit sites, proteins destined to further compartments in the secretory pathway, leave
the ER packaged into transport vesicles and are directed towards the Golgi where they fuse to
form and maintain the ���-Golgi compartment. Upon processing and maturation, they progress
to the �����-Golgi compartment and thus form the trans-Golgi network (TGN). Proteins
destined for secretion are sorted into one of two types of vesicles according to the secretion
pattern of the protein. Some proteins are secreted continuously and these vesicles immediately
move to the plasma membrane, fuse and release their contents by exocytosis. Other proteins
are exported by regulated secretion. They accumulate in secretory vesicles awaiting a stimulus
for controlled exocytosis. This directional membrane flow is balanced by retrieval pathways,
which bring membrane and selected proteins back to the compartment of origin.
3.2 General mechanisms of vesicular transport
The principal element of vesicular traffic is that vesicles bud from a donor compartment and
fuse with an acceptor compartment. Cargo proteins that are loaded into the forming vesicle
are thereby delivered to the acceptor compartment. To provide specificity to the transport
mechanism, several proteins on the donor compartment, the vesicle membrane and the
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acceptor compartment interact under carefully regulated conditions. The biogenesis of
transport vesicles is initiated through the recruitment of large multi-subunit protein complexes
termed coats. The coat is thought to perform two principal functions. It integrates specific
membrane proteins into the vesicle membrane that help to select the cargo protein and it
curves and deforms the membrane, eventually leading to the release of coated transport
vesicles from the donor compartment (Bonifacino and Lippincott-Schwartz, 2003).
Dependent on the type of coats the vesicles are recruited to a specific membrane compartment
within the cell.
The best studied trafficking pathways are those that use carrier vesicles clearly identifiable by
their coats, made of the coatmer COPI, COPII, or clathrin and its partners (see Figure 3).
During the formation of a vesicle, a limited set of coat proteins carries out a programmed set
of sequential interactions that lead to budding from the parent membrane, uncoating, fusion
with a target membrane, and recycling of the coat components. There are clear similarities
and differences between the ways that COPI, COPII and clathrin coats handle these steps.
COPI and COPII vesicles traffic between the endoplasmic reticulum and the Golgi complex -
COPI primarily retrograde from the Golgi to the ER and between Golgi cisternae, and COPII
anterograde from the ER to the Golgi. The clathrin pathway has two major routes, from the
plasma membrane to the early endosome and from the Golgi to the endosome. Other
structures have been observed in the cell, which do not have COP or clathrin coats.
Internalization from the plasma membrane can also occur via macropinocytosis and
phagocytosis.
Before the vesicle fuses with the acceptor membrane the coat is discarded. The next steps in
the fate of a transport vesicle involve proteins of the Rab GTPase family. Rabs interact with
different proteins, loosely termed Rab effectors. Rab effectors perform diverse functions from
vesicle budding to vesicle transport and vesicle docking at the target membrane (Bock et al.,
2001). Different Rabs are localised on distinct vesicles and organelles. Due to their specific
localisation and to their ability to regulate their activity, Rabs can recruit and/or activate their
various effectors at the correct time and to the correct place, providing an element of
regulation to the vesicle-trafficking machinery (Bock et al., 2001). The final step in vesicle
trafficking is the fusion of a vesicle with its target membrane, believed to be mediated by a
family of proteins termed soluble NSF-attachment receptors (Bonifacino and Glick, 2004).
SNAREs are integral membrane proteins present on both vesicle and target membranes, and
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can form very stable complexes, termed SNAREPIN complexes. The formation of a
SNAREPIN complex pulls the vesicle and target membrane together and may provide the
energy to provoke fusion of the lipid bilayers (Bonifacino and Glick, 2004).
Figure 3: The major membrane trafficking pathways that use carrier vesicles with
COPI, COPII and clathrin in eukaryotic cells.
In the biosynthetic pathway, newly synthesized molecules are transported from the
endoplasmic reticulum to the Golgi and from one cisterna of the Golgi to the next until they
reach the ����� Golgi network. There, sorting occurs, directing traffic to the plasma membrane
or to endosomes. In the endocytic pathway, macromolecules are internalized at the plasma
membrane and forwarded to early endosomes, from where they are either recycled to the
plasma membrane through recycling endosomes or forwarded towards degradation in late
endosomes and lysosomes (Kirchhausen, 2000).
3.3 Trafficking signals
The discovery of the “Signal Hypothesis’’ led Gunter Blobel to win the 1999 Nobel Prize for
Medicine. Blobel discovered that protein “zip codes’’ exist for directing proteins to
subcellular compartments such as the nucleus, cytoplasm, mitochondria, endoplasmic
reticulum, lysosomes and endosomes, peroxisomes, Golgi, and nucleolus. Proteins need to be
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Targeted subcellular compartment Signal(s)
Nucleus Monopartite PKKKRKV
Bipartite KRPAATKKAGQAKKKKLDK
Cytoplasm (export from nucleus) LX(1-3) LX(2-3) LXJ
(L = Leu X = spacer J = Leu, Val or Ile)
Mitochondria ��S��QS�������T�T�
(amphipathic alpha helix)
+ charged residues on one side (italics);
non-polar residues on the other side (bold)
Endoplasmic reticulum (return to ER) KDEL at C-terminu s
Lysosomes and endosome s Tyrosine-based sorting signals: NPXY or YXX
Di-leucine-based [DE]XXXL[LI] and DXXLL
consensus motifs
Peroxisomes SKL at C-terminu s
Trans-golgi network Di-leucine motif followed by two acidic clusters:
����������� (acidic clusters italicized)
Nucleolus Basic stretches of aa’s such as
RRRANNRRR
KKKMKKHKNKSEAKKRKI
directed to their proper cellular compartments in order to perform their functions. For
example, most transcription factors need to be in the nucleus to promote gene expression.
Some proteins, such as the glucocorticoid receptor, may start in one compartment
(cytoplasm), and move to another compartment (nucleus) in response to a stimulus (ligand). It
is astonishing, that a signature, which is only few amino acids long, can be precisely
recognized by effector proteins and leads to error-free delivery to the assigned location. The
table below summarizes targeting motifs of some subcellular compartments and exemplifies
the simplicity and beauty of this trafficking system.
Table 1. Signal sequences for subcellular compartments in eukaryotic cells (Davis et al.,
2006).
3.4 Trafficking in ���������� ����������
The malaria parasite �� ���������� has a range of unique organelles all fed by the protein
secretory pathway. These protein transport pathways are fundamental to the biology and
pathology of �� ���������� infection, especially during its intracellular existence in the red
blood cell. PfEMP1, a key player in the parasite’s immune evasion strategies and major
virulence factor, is trafficked via a complex export route, traversing two membranes (PM and
PVM) and the Maurer’s clefts, and finally being inserted at its terminal destination at the host
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cell surface. There it mediates cytoadherence to the endothelium and thus prevents clearance
by the spleen. It represents products of antigenic variation - a sophisticated way of immune
evasion. Understanding processes such as the trafficking of PfEMP1 are crucial for the
understanding of the parasite biology and also have great potential as targets for intervention.
A classical protein secretory pathway requires some key components such as an
endoplasmatic reticulum and a Golgi apparatus. However, little is known about the molecular
organization of the secretory pathway of �� ����������. The ER resembles a simple
perinuclear structure with two protruding ‘horns’ (van Dooren et al., 2005), whereas the Golgi
is rudimentary with a so-called ‘unstacked’ conformation (Elmendorf and Haldar, 1993b; Van
Wye et al., 1996; Struck et al., 2005). Like all eukaryotic cells, �� ���������� must rely on a
huge supply of molecular machinery to shuffle proteins through membranes and in and out of
vesicles in order to target them to their correct destination (Bock et al., 2001). The genome of
�� ���������� has many homologues of core secretory proteins such as the COP components
and GTPases (Gardner et al., 2002) but there is very little experimental evidence for the
specific role of any of these components.
Like in other eukaryotes, soluble and membrane proteins destined for secretion are directed
into the ER by recognition of a classical signal sequence or a recessed signal sequence (Cooke
et al., 2004). Proteins most probably pass through a rudimentary Golgi where additional
protein-targeting motifs provide essential information for subsequent targeting to secretory
destinations (Tonkin et al., 2006). In absence of other signals, the parasitophorous vacuole
appears to represent the default destination for secreted proteins in �� ���������� (Waller et
al., 2000; Wickham et al., 2001; Adisa et al., 2003; Marti et al., 2004). There are at least 11
secretory destinations in �� ���������� and some of the signals and pathways of proteins
travelling to such destinations have recently been revealed and are summarized below.
-Trafficking to the host red blood cell: Recently, two independent groups published the
PEXEL/VTS (���������� export element/vacuolar targeting signal) targeting motif that is
responsible for the translocation across the PVM (Hiller et al., 2004; Marti et al., 2004). It is
located 15-20 amino acids downstream of the NH2-terminal hydrophobic sequence and
mediates export of proteins from the PV across the PVM. The consensus sequence is
R/KxLxQ/E. Interestingly, this motif is found in both soluble and membrane proteins which
are exported into the RBC cytosol. This implies that there is a common machinery responsible
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for protein export in the PVM. The nature of this translocon- the complex of molecules
associated with the translocation of proteins across lipid bilayers-however is still unknown.
Preliminary bioinformatics analysis of the ���������� genome indicates that it has genes
encoding sec61 translocation, mitochondrial and possibly chloroplast machineries (Marti et
al., 2005).
-Trafficking to the food vacuole: Hemoglobin proteolysis is accomplished by a series of
parasite-derived proteases (Klemba et al., 2004b). All of the known FV proteases bear a
putative N–terminal signal peptide, signifying that they are transported through the
endoplasmic reticulum, and a prodomain that might have a role in targeting from the ER to
the FV. Recently, the targeting of two FV-targeted proteases has been studied in detail and
they have been shown to traffic to the FV by two different routes: Plasmepsin II travels via
ER to the food vacuole (Klemba et al., 2004a), whereas the dipeptide aminopeptidase1 does
not traffic directly to the food vacuole but instead accumulates in the parasitophorous vacuole
before moving to the food vacuole (Klemba et al., 2004a; Klemba et al., 2004b).
-Protein trafficking to the apicoplast: The apicoplast is surrounded by four membranes and
most apicoplast proteins are nuclear-encoded and require a bipartite N–terminal extension
made up of a signal peptide and a transit peptide (Waller et al., 2000). Earlier work has shown
that the signal peptide resembles a classical eukaryotic signal peptide and mediates targeting
into the ER whereas the transit peptide mediates all remaining steps. Interestingly, it has been
shown, that apicoplast-targeted proteins do not traverse the Golgi but rather divert straight
from the ER to the apicoplast (van Dooren et al., 2001; DeRocher et al., 2005).
Recent advances in plasmodial trafficking mechanisms have substantially contributed to the
understanding of cellular processes of the parasite. The discovery of the PEXEL/VTS motif
has enabled the prediction of the whole “exportome”. This will help to decipher new parasite
proteins that are on the host cell surface and may contribute to new vaccine targets. However,
the whole translocation process across the PVM is not understood and a set of established
exported markers do not fit into the predicted exportome. MAHRP1 is an exported protein,
which has been confirmed to be associated at the Maurer’s clefts by immunofluorescence and
transfection technology. However, it does not contain an ER signal sequence and it does not
bear a PEXEL motif. Is there an alternative trafficking pathway for exported proteins that do
not contain a PEXEL/VTS motif? Is there maybe a timing-dependant alternative export
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pathway, which overrules the PEXEL/VTS-dependant pathway? We have tackled this
question in two different studies shown in chapter 3 and 4.
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Using a stage-specific cDNA library from Plasmodium
falciparum we have identified a gene coding for a novel
histidine-rich protein (MAHRP-1). The gene is exclu-
sively transcribed during early erythrocyte stages and
codes for a small transmembrane protein. The C-termi-
nal region contains a polymorphic stretch of histidine-
rich repeats. Fluorescence microscopy studies using
polyclonal mouse sera revealed thatMAHRP-1 is located at
the Maurer’s clefts, which represent parasite-induced
structures within the cytosol of infected erythrocytes. Bio-
chemical studies showed that recombinantMAHRP-1binds
the toxic hemoglobin degradation product, ferriprotopor-
phyrin (FP) with a submicromolar dissociation constant
and a stoichiometry determined by the number of DHGH
motifs. The bound FP has increased peroxidase-like activ-
ity and is 10-fold more susceptible to H2O2-induced degra-
dation compared with unbound FP. These properties of
MAHRP-1 suggest it may play a protective role against ox-
idative stress, and its location at the Maurer’s clefts sug-
gests a function in promoting the correct trafficking of ex-
ported proteins, such as P. falciparum erythrocyte
membrane protein-1.
Plasmodium falciparum causes one of the most life-threat-
ening infectious diseases of humans. Malaria is estimated to be
responsible for up to 2 million deaths per year. The pathogen-
esis of the disease is associated with the intracellular erythro-
cytic cycle of the parasite involving repeated rounds of inva-
sion, growth, and schizogony. P. falciparum invades enucleated
(mature) erythrocytes, which are devoid of organelles and lack
a biosynthetic and secretory machinery and are, thus, metabol-
ically relatively inert. The parasite feeds on the host cell cytosol
and degrades about 75% of the hemoglobin (1). The released
amino acids are incorporated into parasite proteins and also
appear to be available for energy metabolism. Proteolysis is
thought to be essential for parasite survival because P. falcip-
arum has a limited capacity for de novo amino acid synthesis
(2). However, the proteolytic degradation of hemoglobin also
produces heme (ferriprotoporphyrin IX (FP)1). Free intracellu-
lar FP is toxic due to its detergent-like (3) and redox properties
(4). The parasite appears to dispose of FP largely by sequestra-
tion in the parasite’s food vacuole as a granular pigment known
as hemozoin (�-hematin) (5, 6). It has been shown previously
that this crystallization process is initiated and accelerated in
vitro by parasite-derived histidine-rich proteins (7, 8), and the
inhibition of hemozoin formation is believed to underlie the
mode of action of chloroquine in vivo (9). It has also been
suggested that non-enzymatic degradation, including reactions
with H2O2 and glutathione may contribute to heme detoxifica-
tion (1, 10) and that histidine-rich proteins may modulate these
processes (8).
Several parasite-encoded histidine-rich proteins (HRP) have
been described, of which P. falciparum histidine-rich protein 2
(HRP2) is one of the best characterized. This soluble protein is
found in the food vacuole but also in the erythrocyte cytosol (8,
11). Earlier studies suggested that HRP2 is ingested by the
parasite’s cytostome from the red cell together with hemoglobin
and thereby delivered to the food vacuole by bulk endocytosis
(7). However, recent studies show that although �75% of the
hemoglobin is ingested by the parasite, more than 90% of HRP2
remains in the erythrocyte cytosol (12). Cytosolic HRP2 seems
to concentrate mainly near the periphery of the erythrocyte,
suggesting that it may not diffuse freely through the erythro-
cyte cytoplasm and could thereby avoid ingestion. These recent
findings suggest the possibility that HRP2 could play a role in
the detoxification of the by-products of hemoglobin degradation
in the host cytoplasm. Recently, it has been shown that HRP2
modulates the redox activity of FP and that the HRP2�FP
complex may have antioxidant properties (13). Hence, the lo-
cation of HRP2 near the erythrocyte membrane may function to
protect the host membrane from oxidative stress and, thus,
prevent premature host cell lysis.
The P. falciparum knob-associated histidine-rich protein
(KAHRP) is another well characterized HRP. KAHRP is essen-
tial for the formation of knob-like protuberances on the surface
of infected erythrocytes. These knobs act as platforms for the
presentation of P. falciparum erythrocyte membrane protein-1
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(PfEMP1), which is responsible for adherence of parasitized
erythrocytes to vascular endothelial cells (14). This adhesion
and subsequent accumulation of infected erythrocytes in the
microvasculature are pivotal events in the pathogenesis of
P. falciparum malaria, and these processes are considered to
represent major virulence factors.
On route to the erythrocyte membrane, KAHRP is tran-
siently located at the Maurer’s clefts, a parasite-derived vesi-
cle-like structure in the erythrocyte cytosol (15). Other proteins
have also been shown to be associated with Maurer’s clefts,
including PfEMP3 (15, 16), Pf322 (17), and P. falciparum skel-
eton-binding protein 1 (PfSBP1) (18). It has been suggested
that these cleft structures may act as an intermediate traffick-
ing compartment and may play a critical role in the organiza-
tion and sorting of parasite proteins. In a host cell such as the
erythrocyte, which is devoid of any organelles or trafficking
machinery, such parasite-derived structures represent an in-
teresting target for possible intervention.
Here we describe a novel P. falciparum membrane-associ-
ated histidine-rich protein, MAHRP-1, which localizes to the
Maurer’s clefts. We identified the sequence encoding MAHRP-1
in a ring stage-specific cDNA library (19) and show that
MAHRP-1 is exclusively expressed in the early erythrocytic
stages but is present throughout the cycle. MAHRP-1 contains
a predicted transmembrane domain and a polymorphic cluster
of histidine-rich repeats. MAHRP-1 binds FP in vitro in a
specific manner, promoting the peroxidase-like activity of FP
and enhancing the degradation of FP by H2O2. These data
suggest that MAHRP-1 might play an important role in gener-
ating the Maurer’s clefts or in protecting proteins within these
structures against the noxious effects of FP and reactive oxy-
gen species.
MATERIALS AND METHODS
FP (porcine), bovine serum albumin (essentially fatty acid free
(BSA)), saponin, and ortho-phenylenediamine (OPD) were obtained
from Sigma. Albumax was provided by Invitrogen. All primers were
manufactured by Invitrogen. Escherichia coli BL21 strain and plasmid
vector pGEX-6P-2 were obtained from Amersham Biosciences. E. coli
TunerDE3pLacI was obtained from Novagen. The sequencing vector
pGEM-T was provided by Promega, Wallisellen, CH. Glutathione S-
transferase (GST) was expressed from the pGEX-6P-vector and purified
as described for the recombinant MAHRP-1c. Secondary antibodies for
immunoblot analyses were goat anti-mouse IgG (�-chain specific) alka-
line phosphatase-labeled (Sigma) and goat anti-rabbit IgG (heavy and
light chain)-alkaline phosphatase-labeled (Jackson ImmunoResearch
Laboratories, West Grove, PA). Secondary antibodies for immunofluo-
rescence labeling were goat anti-mouse IgG conjugated to Alexa 568
(Molecular Probes) and goat anti-rabbit IgG conjugated to fluorescein
isothiocyanate (Sigma or Dako). Rabbit antisera recognizing KAHRP,
PfEMP3, P. falciparum exported protein-1 (EXP-1), and PfEMP1 were
kindly donated by Kathy Davern and Dr. Jacqui Waterkeyn, Walter
and Eliza Hall Institute of Medical Research, and Prof. Klaus
Lingelbach, Philipps-University, Marburg, Germany, and Professor
Chris Newbold, John Radcliffe Hospital, Oxford, UK.
Methods
In Silico Analyses—One of the ring stage-specific gene fragments
reported in Spielmann and Beck (19) coded for a histidine-rich protein
(AJ290925). Query of the malaria sequence data base (www.plasmodb.
org) returned the complete gene, now referred to as mahrp1. The
predicted intron sequence was removed from the complete gene se-
quence to obtain the open reading frame. This was translated into
amino acid sequence using ExPASy Molecular Biology Server (www.
expasy.ch). Protein primary structure analysis was performed using
www.psort.nibb.ac.uk.
Amplification and Sequencing of Full-length MAHRP-1—The se-
quence coding for MAHRP-1 was amplified from a collection of DNA
derived from the following P. falciparum strains: 3D7, K1, SN250,
ITG2F6, IFA18, Mad20. Primers used for amplification by PCR were:
forward primer, 5�-GTTCCTACTGTTGGAACAGTTCC-3�, and reverse
primer, 5�-CTAATTTTGCTTTTTGGCAATCACATGG-3�. The PCR pro-
ducts were cloned into the sequencing vector pGEM-T. The commer-
cially available SP6 and T7 primers were used for sequencing reactions.
Expression of Recombinant MAHRP-1c—The sequence coding for the
C-terminal domain of MAHRP-1 was PCR-amplified from both 3D7 and
ITG2F6 genomic DNA using primers 5�-CAGATCAAGAGTGAACATA-
AAGCC-3� and 5�-CTAATTTTGCTTTTTGGCAATCACATGG-3�. The
PCR product was cloned into the SmaI restriction site 3� of GST in
pGEX-6P-2 by cycle restriction ligation to yield the plasmid pMAHRP-
1c. E. coli BL21strain (for the 3D7 fusion protein) and E. coli Tuner
DE3pLacI (for the ITG2F6 fusion protein) were transformed with plas-
mid pMAHRP-1c and used for expression of recombinant MAHRP-1c.
Luria broth was inoculated with E. coli harboring pMAHRP-1c and
cultured overnight at 37 °C containing one (for 3D7) or both (ITG2F6) of
the following antibiotics: ampicillin (100 �g/ml) and chloramphenicol
(34 �g/ml). Fresh Luria broth containing antibiotics was inoculated
with the overnight culture at a dilution of 1:10 and cultured at 37 °C to
an A600 of 1.0. Expression of MAHRP-1c was induced by adding isopro-
pyl-1-thio-�-galactopyranoside to a final concentration of 1 mM. Induced
cultures were grown for 3–6 h at 37 °C.
Purification of Recombinant MAHRP-1c—Induced cultures were
harvested by centrifugation and resuspended in lysis buffer (2 mg/ml
lysozyme, 2 mM phenylmethylsulfonyl fluoride, 2 mg/ml DNase) in 137
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4
(phosphate-buffered saline (PBS)) and lysed by sonication. The super-
natant containing the soluble GST fusion protein was purified using the
Bulk GST Purification Module (Amersham Biosciences) as recom-
mended by the manufacturer. Purity and integrity of the protein was
checked on a 12.5% SDS-PAGE. 500 ml of culture yielded �2–4 mg of
recombinant protein. To test whether the histidine residues could also
be used for further purification, an aliquot of the protein preparation
was run over a Ni2� chelate column (Qiagen) according to the supplier’s
protocol (data not shown).
Production of Specific Sera—C57BL6 mice were immunized subcu-
taneously with 10 �g of recombinant MAHRP-1c excised from polyacryl-
amide gels. Mice were boosted three times within 7 weeks and bled 1
week after the last immunization. Specificity of sera was tested on
Western blots with recombinant MAHRP-1c, recombinant GST, and
parasite protein extracts. Four different mice antisera were generated,
each of which gave equivalent reactivity profiles.
Western Blot Analyses—Samples were subjected to electrophoresis
on 12.5% SDS-polyacrylamide gels and transferred to nitrocellulose
(Hybond-C extra, Amersham Biosciences) for 1.5 h using a Trans-Blot
semi-dry electroblotter (Bio-Rad). The membrane was washed twice for
5 min in TNT (0.1 M Tris/HCl, 1.5 M NaCl, 0.05% Tween 20, pH 8.0) and
blocked in TNT and 5% milk powder overnight at 4 °C. The primary
antibody was diluted in 15 ml of TNT and 1% milk powder, and the
secondary antibody was diluted in 15 ml of TNT and 0.1% milk powder.
The membrane was washed 4 times in TNT and twice in Tris buffer (0.1
M Tris/HCl, 0.5 mMMgCl2, pH 9.5). The membrane was stained in 20 ml
of Tris buffer containing 200 �l of 5-bromo-4-chloro-3-indolyl phosphate
(15 mg/ml) and 200 �l of nitro blue tetrazolium (30 mg/ml 70% N,N-
dimethylformamide) for 15 min and then washed in distilled H2O.
Antibodies for immunoblot analyses were used at following dilutions:
mouse anti-MAHRP-1c, 1/1000; rabbit anti-KAHRP, 1/200; rabbit anti-
HRP2, 1/200; goat anti-mouse, 1:2000; goat anti-rabbit 1/30000.
Parasite Culture and Preparation of Parasite Protein Extracts—
P. falciparum 3D7 strains were cultured at 5% hematocrit as described
(20) using RPMI medium supplemented with 5% human serum or 0.5%
Albumax (21). Parasites were synchronized with 5% sorbitol (22).
For total parasite extracts infected erythrocytes from a 10-ml culture
(5% hematocrit, 10% parasitemia) were lysed with 0.03% saponin for 20
min on ice, washed in PBS, and resuspended in Laemmli sample buffer.
Triton-X-114 phase separation was performed as previously described
(23). Briefly, 10 ml of parasite culture (15–20% parasitemia) was sapo-
nin-treated, and the pellet was washed with PBS and then resuspended
in 500 �l of human tonicity phosphate-buffered saline (HTPBS: 137 mM
NaCl, 2.7 mM KCl, 8.1 mM sodium phosphate, pH 7.2) containing 0.5%
Triton-X-114 and 1 mM phenylmethylsulfonyl fluoride and stored at
�20 °C until use. After thawing, the extract was kept on ice for 30 min
with intermittent mixing. The extract was spun at 15,000 � g for 20
min to pellet insoluble material. The supernatant, containing the de-
tergent-soluble proteins, was layered over a 0.4-ml ice-cold sucrose
cushion (6% sucrose, 0.06% Triton-X-114 in HTPBS), incubated at 37 °C
for 5 min, and centrifuged at 500 � g for 5 min at room temperature.
The resulting three phases were treated as follows. (i) The upper layer
(detergent-depleted fraction) was collected; (ii) the sucrose cushion was
discarded; (iii) the detergent pellet, containing the membrane proteins,
was resuspended in 0.5 ml of HTPBS, the purification over a sucrose
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cushion was repeated, and the pellet was resuspended in 0.5 ml of
HTPBS. Both the detergent-depleted fraction (i) and the final detergent
fraction (iii) were precipitated with tricarboxylic acid and analyzed by
SDS-PAGE.
LocalizationStudiesUsingIndirectImmunofluorescenceMicroscopy—
Infected erythrocytes were smeared onto glass slides and fixed in ac-
etone:methanol (1:1 v/v) at �20 °C for 10 min. Slides were partitioned
into wells using a hydrophobic pen and incubated for 1 h in a humid
chamber with one or both of the following primary antibodies: mouse
anti-MAHRP-1c (1:1000), rabbit anti-PfEMP3 (1:50), rabbit anti
PfEMP1 (1:200). The primary antibody was washed off with PBS or 1%
Tween 20 in Tris-buffered saline, and the slides were then incubated
with one or both secondary antibodies: fluorescein isothiocyanate-con-
jugated anti-rabbit IgG (1:250) and Alexa 568-conjugated anti-mouse
IgG (1:50). The slides were mounted in 90% glycerol containing 0.05%
N-propyl gallate (Sigma) to reduce bleaching. Samples were viewed
using an Olympus BX50 light microscope fitted with a fluorescence
attachment and a SPOT RT digital camera or with a Leica TCS-NT
laser-scanning confocal microscope at the Confocal Microscopy Facility,
Monash University.
FP Binding Studies—The interaction between FP and the recombi-
nant proteins was examined spectrophotometrically in PBS, pH 7.4.
Concentrated stock solutions of FP (10 mM) were freshly prepared in 0.1
M NaOH and diluted in water as required. Absorption spectra were
recorded using a Cary 1E spectrophotometer. The absorption spectrum
of FP exhibits a time-dependent change due to gradual self-association
events (24). Therefore, spectroscopic measurements of FP in the pres-
ence of protein were recorded 2 min after mixing the FP stock into the
protein solution.
Redox Activity of FP—The H2O2-mediated decomposition of FP at pH
FIG. 1. Primary structure of P. falciparum 3D7MAHRP-1. A, schematic representation of themahrp1 gene and deduced MAHRP-1 protein.
The N-terminal domain is shown hatched, followed by the transmembrane domain (TM), shown in light gray. The C-terminal histidine-rich domain
is shown in dark gray, with DHGH indicating the characteristic repeat motif. B, P. falciparum 3D7 MAHRP-1 amino acid (aa) sequence. The
18-amino acid long transmembrane domain is highlighted in gray, and the C-terminal repeats are indicated in bold. The C-terminal sequence
cloned as GST fusion protein and referred to as recombinant MAHRP-1c is underlined.
FIG. 2. Length polymorphisms in the histidine-rich regions of mahrp1 among different strains of P. falciparum. A, schematic
representation of SspI and NcoI restriction enzyme recognition sites in mahrp1. B, RFLP pattern of SspI- and NcoI-digested mahrp1 alleles of six
different strains, visualized by agarose gel electrophoresis. C, amino acid sequence alignments of MAHRP-1 from 6 different P. falciparum strains.
Repeats are indicated in bold. Amino acid numbering according to the 3D7-coding sequence.
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7.4 was monitored by measuring the decrease in absorbance of FP (5
�M) in the presence or absence of either MAHRP-1c, BSA. or GST (all 2
�M). The reaction (in a final volume of 950 �l) was initiated by the
addition of 50 �l of H2O2 (final concentration 2 mM) and monitored at
20 °C using a Carry 1E spectrophotometer. The initial measured value
for the FP concentration was set as 100%.
To monitor the peroxidase-like activity of FP at pH 7.4, samples (200
�l) containing 5 mM OPD and 5�M FP with or without protein (MAHRP-
1c, BSA, or GST; 0.1–2.0 �M) were added to the wells of a 96-well plate.
The reaction was initiated by the addition of 10 �l of 40 mM H2O2, and
plates were incubated at 20 °C for 20 min. The oxidation of OPD was
measured at 490 nm after the addition of 50 �l of 3 M HCl.
RESULTS
Identification and Primary Structure of MAHRP-1—Using
suppression subtractive hybridization, we identified a set of
genes that are exclusively transcribed in the ring stage of
P. falciparum 3D7 strain, as reported in Spielmann and Beck
(19). Among the 13 ring stage-specific gene fragments obtained,
FIG. 3. Production of recombinant 3D7 MAHRP-1c and immunoblot analysis of anti-MAHRP-1c serum. A, recombinant protein
samples were subjected to SDS-PAGE (12.5% acrylamide) and visualized by Coomassie Blue staining. Shown are the molecular weight marker
(lane a), total protein lysate of E. coli expressing MAHRP-1c (lane b), purified recombinant MAHRP-1c (lane c), and purified recombinant GST (lane
d). B, immunoblot analysis of equal amounts of recombinant proteins (�8 �g/lane), MAHRP-1c (lane a) and GST (lane b), probed with
anti-MAHRP-1c serum. C, immunoblot of saponin-lysed parasite extract probed with anti-MAHRP-1c serum (lane a), anti-HRP2 serum (lane b),
and anti-KAHRP serum (lane c) to test for reactivity with three histidine-rich proteins.
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one coded for a histidine-rich protein (AJ290925). Using the
gene sequence to query the malaria sequence data base re-
vealed that mahrp1 is located on chromosome 13. The deduced
protein and the gene organization are presented in Fig. 1. The
predicted intron sequence was removed from the complete gene
to obtain the open reading frame. The translated sequence
comprises 249 amino acids, with a predicted molecular weight
of 28.9 kDa and a pI of 5.92. MAHRP-1 contains a predicted
transmembrane domain (amino acids 106–124) but no pre-
dicted N-terminal signal sequence. The region C terminus to
the transmembrane domain has a histidine content of nearly
30% and contains 6 tandem repeats of the amino acid sequence,
DHGH, with additional preceding DH repeats.
We examined the degree of conservation of MAHRP-1 among
different strains of P. falciparum. Digestion of six strains with
restriction enzymes SspI and NcoI resulted in four distinguish-
able fragments (Fig. 2). The major length polymorphism was
found in the 160-bp fragment in the histidine-rich region of the
C-terminal domain, between amino acids 195 and 249. Se-
quence analysis revealed that alleles differed in the number of
DHGH repeats, whereby 3D7 has 6 and ITG2F6 has13 repeats.
Immunochemical Characterization of MAHRP-1 in Parasit-
ized Erythrocytes—The C-terminal domain of MAHRP-1 (3D7
strain, amino acids 131–242), referred to as MAHRP-1c, was
expressed as a 41-kDa GST fusion protein in E. coli (Fig. 3A),
and the purified protein MAHRP-1c was used to raise antibod-
ies in mice. The serum recognized the recombinant MAHRP-
1c-GST fusion protein but not recombinant GST on a Western
blot (Fig. 3B). The antiserum recognized a single band of the
predicted size at �30 kDa in an extract of parasitized erythro-
cytes (Fig. 3C, lane a). The antiserum does not appear to
cross-react with other proteins. In particular, it does not rec-
ognize bands corresponding to the �60-kDa protein recognized
by an antiserum against HRP2; Fig. 3C (lane b) or the�90-kDa
band obtained with serum against the KAHRP (Fig. 3C, lane c).
In addition, the anti-MAHRP-1c serum gave no signal on pro-
tein preparations from uninfected erythrocytes (data not
shown).
Infected erythrocytes were treated with detergents to eluci-
date the physical organization of MAHRP-1. Most of the
MAHRP-1 signal was associated with the saponin-insoluble
pellet (Fig. 4A, lane a). Further partitioning of the pelleted
fraction using the detergent Triton X-114 yielded three frac-
tions, i.e. a detergent-soluble fraction, an aqueous (detergent-
depleted) fraction, and an insoluble fraction. MAHRP-1 ap-
peared to be largely associated with the detergent-soluble
fraction, which is consistent with it being a membrane protein
(Fig. 4B, lane c).
Subcellular Location of MAHRP-1—We have used indirect
immunofluorescence microscopy to examine the subcellular lo-
cation of MAHRP-1 in P. falciparum-infected erythrocytes.
MAHRP-1c antibodies reacted with punctuate structures
within the cytoplasm of the host erythrocytes (Fig. 5A). The
pattern obtained resembles the pattern obtained for Pf322 (17),
PfSBP1 (18), and PfEMP3 (14, 16), which has been shown to be
located in parasite-derived membranous structures in the
erythrocyte cytosol, referred to as Maurer’s clefts.
MAHRP-1 was first observed in vesicle-like structures
within the erythrocyte cytosol approximately �10 h post-inva-
sion. As the parasite matured, the labeled structures increased
in number. In the schizont stage, a diffuse staining of the entire
erythrocyte appeared to underlie the punctuate foci.
To confirm the Maurer’s cleft location, we performed dual
labeling studies using an antiserum against PfEMP3 (16),
which has previously been described to be Maurer’s cleft-
located (Fig. 5B). A high degree of colocalization between
PfEMP3 and MAHRP-1 was observed. Dual labeling with
EXP-1, a parasite protein that is exported into the parasito-
phorous vacuolar membrane, indicated that MAHRP-1 is
mainly located outside the parasite confines and within the
confines of the erythrocyte membrane. We also used antisera
against PfEMP1, a protein also transiently located in Maurer’s
clefts (15). As shown in Fig. 5C, there is a tight colocalization of
the erythrocyte cytosol population of PfEMP1 with MAHRP-1
in early trophozoite stages. In mature stages, PfEMP1 is partly
FIG. 4. Solubility studies of MAHRP-1 in 3D7 parasitized erythrocytes. Immunoblot (using �-MAHRP-1c mouse polyclonal antibodies,
visualized with �-mouse-IgG alkaline phosphatase-labeled antibodies). A, parasite pellet (lane a) and supernatant (lane b) after saponin lysis of
infected erythrocytes. B, the pellet was further processed and partitioned into an insoluble fraction (lane a), Triton X-114-depleted fraction, i.e. the
non-membrane fraction (lane b), and Triton X-114-soluble fraction, i.e. membrane fraction (lane c). Lane d contained 0.04 �g of recombinant
MAHRP-1c. All lanes contain protein preparations from a 10-ml culture with 5% hematocrit and 10–20% parasitemia.
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FIG. 5. Immunofluorescence analysis of MAHRP-1 in P. falciparum (3D7) infected erythrocytes. A, a young trophozoite stage-infected
erythrocyte showing distinct punctuate staining within the erythrocyte cytosol (panel 1) and a mature, multinucleated schizont showing punctuate
staining overlaying a more generalized staining (panel 3). The same infected erythrocytes were 4,6-diamidino-2-phenylindole-stained to visualize
the nuclei (2 and 4). B, dual labeling studies with PfEMP3 and EXP-1. Panels 1–4, a young trophozoite-infected erythrocyte examined by bright
field imaging (panel 1) or labeled with MAHRP-1c antiserum (panel 2, red) and PfEMP3 antiserum (panel 3, green). Panel 5–8, a young
trophozoite-infected erythrocyte examined by bright field imaging (panel 5) or for labeling with MAHRP-1c antiserum (panel 6, red) and EXP-1
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redistributed to the erythrocyte membrane, whereas MAHRP-1
remains largely associated with the Maurer’s clefts.
MAHRP-1 Interacts with FP—Because of the high histidine
content of MAHRP-1, we examined the ability of recombinant
3D7 MAHRP-1c to bind to an immobilized metal column. We
found that MAHRP-1c-GST fusion protein bound strongly to a
Ni2�-chelate column and was eluted with imidazole, thus pro-
viding potentially an additional step for purification of the
protein (data not shown).
Given the ability of MAHRP-1 to bind to metal ions and the
proposed function of HRPs in FP detoxification, we examined
the interaction between the protein and FP. Use was made of
the visible absorption spectrum of FP to examine its interaction
with protein. As shown in Fig. 6A, FP exhibits a characteristic
absorption peak known as the Soret band with a maximum at
390 nm and a major shoulder at 350 nm and smaller (� and �)
bands at wavelengths greater than 500 nm. Quantitative spec-
troscopic measurements of FP in aqueous solution are compli-
cated by the presence of an equilibrium between the monomer
and �-oxo dimeric form of the FP, which is both pH- and
concentration-dependent (24, 25). The FP dimer is favored un-
der basic conditions and at high concentrations. Under acidic
conditions, the monomer is favored; however, FP also tends to
aggregate and to form �-hematin crystals (6).
The maximum wavelengths and extinction coefficients for
the FP absorption bands are sensitive to the presence of bound
ligand and can be used to examine an interaction between FP
and FP binding molecules (26). In this work, we examined the
interaction of recombinant MAHRP-1c with FP. We performed
FP binding assays at pH 7.4 in an effort to resemble the
physiological environment of the erythrocyte cytosol. Under
these conditions, FP exhibits a broad Soret band of relatively
low intensity and another much lower intensity band at �620
nm. These features are characteristic of the �-oxo dimer under
basic conditions and indicate that the FP is largely present as
a dimer, probably in equilibrium with some monomeric and
aggregated species. This absorption spectrum is dramatically
altered in the presence of 3D7 MAHRP-1c. There is a sharpen-
ing of the Soret band and a 25-nm blue shift to a wavelength
maximum at 410 nm. In addition, the 620-nm peak disappears,
and two peaks become apparent at 530 and 570 nm. These
results indicate that the FP is present in a monomeric form.
The interaction between the 3D7 MAHRP-1c and FP was
examined in greater detail by titrating 2.5 �M 3D7 MAHRP-1c
with FP. Fig. 6B shows the normalized absorption spectra of
the Soret and � and � bands as a function of the FP:protein
ratio. There is little change in the FP spectrum when it is
present at up to a 4 M excess relative to MAHRP-1c. However,
the spectra exhibit a blue shift and a broadening of the Soret
band and the appearance of the 620 nm band at the higher
ratios examined, indicating the presence of unbound FP. An
examination of the Soret absorbance as a function of added FP
shows an increased absorbance compared with that for the
addition of FP to PBS, with an inflection point corresponding to
a FP:MAHRP-1c ratio of 5 (Fig. 6C, open circles). This indicates
that the stoichiometry is about 5 FP molecules per 3D7
MAHRP-1c, with an affinity in the submicromolar range. This
stoichiometry is roughly consistent with the number of DHGH
motifs in the primary sequence. We also examined binding of
MAHRP-1c from the ITG2F6 strain to FP. Similar spectra were
obtained (not shown); however, the stoichiometric point oc-
curred at a FP:protein ratio of �11:1 (Fig. 6C, open squares).
This is consistent with the increased number of DHGH motifs
present in this protein and supports our hypothesis that DHGH
antiserum (panel 7, green). Merges of the red and green channels are shown in panels 4 and 8. C, dual labeling studies with PfEMP1. Erythrocytes
infected with parasites of increasing maturity (top to bottom) were examined by bright field imaging (left-hand panels) or for labeling with
MAHRP-1c antiserum (second column, red) and PfEMP1 antiserum (third column, green). Merges of the red and green channels are shown in the
right-hand panels. Yellow areas represent regions of co-localization. Bars represent 5 �m.
FIG. 6. Interaction of MAHRP-1c with FP. A, the absorption spec-
trum of FP (10 �M) in PBS was measured in the absence and presence
of 3D7 MAHRP-1c (2.5 �M), BSA (2.5 �M), or GST (2.5 �M). B, normal-
ized absorption spectra of the Soret and � and � bands of FP at different
molar ratios of 3D7 MAHRP-1c. The 3D7 MAHRP-1c concentration was
constant (2.5 �M), and increasing amounts of FP were added. C, Soret
absorption of FP in the absence and presence of MAHRP-1c. Aliquots of
FP were added to PBS in the absence (filled diamonds) or presence of
3D7 MAHRP-1c (2.5 �M) (open rings) or ITG2F6 MAHRP-1c (1.0 �M)
(open diamonds). The lines are regression lines using the points before
and after each stoichiometric point. The two absorbance scales in this
panel differ by a factor of 2.5 to permit a direct comparison of the two
MAHRP-1c proteins.
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represents the FP binding motif.
We also examined the effects of BSA, a known FP-binding
protein, and GST, the fusion moiety present in MAHRP-1c, on
the spectral properties of FP. Fig. 6A shows that both GST and
BSA cause an increase in the absorption of the Soret band, with
only a small red shift and slight sharpening of the band. Sim-
ilarly, the � and � bands have an increased absorption, but
their relative positions are not affected. The different effects on
the spectrum suggest a different mode of FP binding for these
proteins compared with MAHRP-1c. It is likely that the FP
binds to BSA (27) and GST via nonspecific hydrophobic inter-
actions. The increase in absorbance may therefore reflect the
increased solubility or decreased aggregation of the FP in the
presence of these proteins.
Effect of MAHRP-1c on the Redox Properties of FP—FP can
react with H2O2 to form a ferryl (Fe(IV)) intermediate that can
participate in a number of enzyme-like reactions. These reac-
tions can destroy FP and convert H2O2 to the innocuous com-
pounds water and oxygen (1, 28). In earlier studies, we have
shown that the antimalarial drug chloroquine inhibits H2O2-
mediated FP destruction under conditions designed to mimic
the food vacuole (1). We have also shown that HRP2 can mod-
ulate the redox properties of FP (8, 13). In this work, we have
examined the interaction of FP with H2O2 at pH 7.4, the
presumed pH of the erythrocyte cytosol. We find that about
20% of FP is degraded by H2O2 within 20 min at pH 7.4 (Fig.
7A). Interestingly, we found that MAHRP-1c (2 �M) enhances
the initial rate of destruction of 5 �M FP by reaction with H2O2
by 10-fold (Fig. 7A). By contrast, equivalent concentrations of
GST or BSA had no effect on the rate of degradation of FP by
H2O2.
We also examined the ability of FP to catalyze H2O2-medi-
ated oxidation of OPD. At pH 7.4, FP (5 �M) greatly increases
the level of oxidation of OPD (5 mM) by H2O2 (2 mM) (Fig. 7B,
open columns). Varying protein concentrations (0.1–2 �M) were
added to determine the effect of protein on this oxidation proc-
ess. MAHRP-1c substantially increased the level of oxidation of
OPD. It is noteworthy that the 2.2-fold increase in OPD oxida-
tion with 2 �M MAHRP-1c is comparable with the 1.8-fold
increase in OPD oxidization observed with the same amount of
HRP2 at pH 7.4 (8). BSA or GST had relatively little effect on
the level of oxidation of OPD (Fig. 7B).
DISCUSSION
Invasion of mature human erythrocytes, which are devoid of
all subcellular organelles, presents a major challenge to
P. falciparum. To survive and to multiply the parasite needs to
modify the properties of the host membrane. To do this it needs
to establish the machinery for trafficking of proteins beyond its
own boundaries. Shortly after invasion, the parasite begins the
process of exporting proteins to the erythrocyte cytosol. The
initial set of exported proteins may represent the machinery for
the subsequent trafficking of important cargo molecules. In-
deed maturation of the ring stage parasite is associated with
the development of membranous extensions of the parasitopho-
rous vacuole and characteristic Maurer’s clefts with electron-
FIG. 7. Effect of MAHRP-1c on the
redox properties of FP. A, effect of 3D7
MAHRP-1c on H2O2-mediated decomposi-
tion of FP. H2O2 (2 mM) was added to FP
(5 �M) at pH 7.4 either in absence of pro-
tein (crosses) or in the presence of 2 �M
MAHRP-1c (squares) or BSA (diamonds)
or GST (triangles). The FP concentration
was monitored at 400 nm. B, effect of
MAHRP-1c on the peroxidase-like activ-
ity of FP. The ability of MAHRP-1c to
enhance the FP-catalyzed oxidation of
OPD was examined in triplicate at pH
7.4. Oxidation of OPD required the pres-
ence of both FP and H2O2 (open columns).
Proteins were added at increasing concen-
trations of 0.1 �M (1), 0.5 �M (2), 2.0 �M (3)
in the presence of FP and at 2.0 �M pro-
tein in the absence of FP (4).
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dense coats that can be observed by electron microscopy in the
host cytosol. By the late ring stage, a number of parasite-
encoded proteins are present in the erythrocyte cytosol, bound
to the cytoskeleton, or inserted into the erythrocyte membrane
(29–31). The Maurer’s clefts are thought to be an important
intermediate compartment in the trafficking of proteins to the
red blood cell membrane (15); however, very little is known
about the molecular components of the Maurer’s clefts or the
molecular basis of the function of these parasite-derived
structures.
In an attempt to identify crucial processes and possibly tar-
gets for intervention, we have generated a stage-specific cDNA
library from early erythrocytic stages (19). Among a small set of
genes exclusively expressed during the ring stage, we have
identified MAHRP-1. Its tightly regulated early expression, a
putative transmembrane domain, and the presence of a histi-
dine-rich domain made it a prime candidate for further inves-
tigation. Several histidine-rich proteins have been described in
P. falciparum with interesting structural and functional prop-
erties (7, 8, 13, 32–34), but MAHRP-1 is the first membrane-
associated HRP.
MAHRP-1 is a small (28.9 kDa) protein with no significant
homology to any known protein. It has no predicted N-terminal
signal sequence but has a 16-amino acid long putative transmem-
brane domain (Fig. 1). Its C-terminal domain contains a histi-
dine-rich region comprising a variable number of DHGH repeats.
We have shown that polymorphism exists between different
P. falciparum strains, which is confined to the histidine-rich
domain, and in particular to the number of DHGH repeats.
Specific antisera were generated against the MAHRP-1 C-
terminal domain. These antisera recognized a 29-kDa protein in
parasite extracts and did not cross-react with two other parasite-
derived histidine-rich proteins, KAHRP and HRP2. The antisera
were used to study the location and organization of MAHRP-1.
Immunofluorescence microscopy studies indicated that
MAHRP-1 is located in the erythrocyte cytosol as clearly defined
foci in a similar pattern to that observed for PfSBP1, Pf332, and
PfEMP3 (16–18). Indeed, in dual-labeling studies we found a
high degree of colocalization of MAHRP-1 with PfEMP3. Maur-
er’s clefts have been visualized by electron microscopy as long,
slender structures coated with electron-densematerial (35, 36). It
is likely that MAHRP-1 is anchored via its transmembrane do-
main in the bilayer that delineates these structures. Very little
MAHRP-1 is detected inside the parasite’s cytosol or in the para-
sitophorous vacuole, indicating that the protein is rapidly trans-
located into the erythrocyte cytosol upon expression.
The Maurer’s clefts appear to be a transit depot in the export
of PfEMP1 to the erythrocyte membrane (15). PfEMP1 is a
family of proteins with a variable extracellular segment con-
taining cysteine-rich binding domains that are responsible for
cytoadherence to the vascular endothelium. PfEMP1 is pro-
duced in ring stage parasites and trafficked to the erythrocyte
surface (via the Maurer’s clefts) about 20 h after invasion (15,
16, 37, 38). In this work, dual labeling studies were used to
confirm that PfEMP1 is located in the same compartment as
MAHRP-1 at least for part of the intraerythrocytic cycle. Thus,
MAHRP-1 might play a direct or indirect role in the trafficking
of this critical virulence factor.
Although KAHRP and PfEMP1 are transiently associated
with the Maurer’s clefts (16), MAHRP-1 appears to reside in
these organelles throughout the parasite’s development. Upon
maturation of the parasite, the Maurer’s clefts increase in
number and are often observed in close apposition to the pe-
riphery of the host cell; however, they do not appear to fuse
with the erythrocyte membrane. It is possible that MAHRP-1
has a structural role in the Maurer’s clefts. Indeed it is possible
that the electron-dense appearance of the Maurer’s clefts in
electron microscopy studies is due to binding of the heavy metal
electron microscopy stain to the histidine moieties in
MAHRP-1. However, it is also possible that MAHRP-1 plays an
active role in protein trafficking, such as in the sorting or
chaperoning of proteins such as PfEMP1.
It is interesting to note that MAHRP-1 is slightly acidic (pI�
5.92). This could allow an interaction with basic residues
within KAHRP (pI � 9.2). In this regard, it is useful to note
that PfEMP1 has a highly acidic cytoplasmic domain (pI �
4.50), which has been shown to interact with domains of
KAHRP (39).
We also performed detergent solubility studies that are con-
sistent with MAHRP-1 being located in Maurer’s cleft mem-
branes. Saponin is a cholesterol binding detergent that perfo-
rates the erythrocyte membrane, releasing soluble, cytosolic
proteins such as hemoglobin. MAHRP-1 was found in the pellet
fraction after saponin treatment, which is consistent with pre-
vious studies suggesting that the Maurer’s clefts remain asso-
ciated with the erythrocyte membrane upon host cell lysis (18,
35). Further fractionation of the parasite samples using two
phase-forming Triton X-114/water mixtures revealed that the
protein is largely soluble in Triton-X-114. This is consistent
with MAHRP-1 being a membrane-embedded protein.
It is interesting to speculate on the possible sequence signals
for trafficking of proteins to the Maurer’s clefts. Apart from
PfEMP1, only one Mauer’s cleft-associated membrane protein
(PfSBP1) has been described previously (18). Like MAHRP-1,
PfSBP1 and PfEMP1 have a single transmembrane domain and
lack a classical N-terminal secretory signal (18, 40). For mem-
brane proteins lacking an N-terminal signal, the transmembrane
domain can act as a start transfer signal for translocation into
the ER membrane. The transmembrane domain can also contain
information for trafficking to particular compartments such as
the Golgi (41). Thus, the transmembrane segments of MAHRP-1,
PfSBP1, and PfEMP1 may contain the signal for export to the
Maurer’s clefts. By contrast, other parasite-encoded membrane
proteins, such as EXP-1, EXP-2, and AMA-1, which are not
exported past the parasitophorous vacuole membrane, have clas-
sical N-terminal signal sequences (42–44).
The mode of insertion of membrane-embedded proteins into
the ER membrane determines their final orientation. Mem-
brane proteins that lack an N-terminal signal sequence can be
inserted into the ER with the N-terminal region facing the ER
lumen (type Ib orientation) or the cytoplasm (type II orienta-
tion) (for review, see Ref. 45). Analysis of the MAHRP-1 se-
quence using the Psort algorithms (available at psort.nibb.
ac.jp) suggests a type Ib orientation. PfEMP1 and PfSBP1 are
also predicted to be type Ib proteins and are known to be
exported to the erythrocyte cytosol with their C-terminal re-
gions facing the erythrocyte cytoplasm (18, 40). Thus, it ap-
pears likely that the histidine-rich C-terminal domain of
MAHRP-1 also faces the host cytoplasm.
Given its location in the Maurer’s clefts and the prominent
histidine-rich domain, we considered the possibility that
MAHRP-1 might play a role in protecting the parasite from the
deleterious effects of FP. The parasite degrades hemoglobin as a
source for amino acids, and the consequent byproducts such as
FP and H2O2 are highly toxic (for review, see Ref. 46). Recently it
has been reported that �90% of the �15 mM heme that is re-
leased from hemoglobin is sequestered as hemozoin (6). Nonethe-
less, it is likely that a fraction of the pool of released FP escapes
sequestration and diffuses down the concentration gradient into
the parasite cytosol. FP readily crosses membranes and would be
expected to rapidly equilibrate throughout the cell. Indeed sig-
nificant levels of free FP (�100 �M) are distributed between the
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parasite and host compartments (1, 10).
As a consequence of its toxic waste products, the parasite
confers a high level of oxidative stress on the host cell (47). This
leads to deposition of hemichromes at the cytoplasmic surface
of the erythrocyte membrane and binding of autoantigens to
the external surface (48). Indeed it has been suggested that
P. falciparum alters the permeability of the erythrocyte by
applying a controlled oxidative stress to the host cell mem-
brane (49). It appears likely therefore that the parasite would
produce proteins to modulate the effect of FP and reactive
oxygen species on the host cell. For example, HRP2 has been
suggested to play a role in detoxification of the byproducts of
hemoglobin digestion (7, 8, 12, 13).
In this work we have examined the ability of the histidine-
rich C-terminal domain of MAHRP-1 to interact with FP and to
modulate its redox properties. A spectroscopic analysis showed
that in the absence of protein, at pH 7.4 FP exhibited a broad
Soret peak. This may reflect the dominance of FP �-oxo dimers
and the presence of some aggregates. Upon the addition of
proteins such as BSA or GST that interact with FP by hydro-
phobic interactions, there was an increase in the Soret absorp-
tion indicative of increased solubilization of the dimeric form of
FP. Upon the addition of MAHRP-1c, there was a sharpening
and a red shift of the Soret band of FP as well as changes in the
red region of the spectrum. Similar changes have also been
reported with FP titrated with imidazole (50) or with HRP2 (8,
51). Thus, the results indicate that in the presence of MAHRP-
1c, the FP is present in a monomeric form presumably coordi-
nated to histidines within the protein in a similar fashion to
that for HRP2.
Our stoichiometric analysis reveals that 3D7 MAHRP-1c
binds FP at a ratio of 1:5, whereas the ITG2F6 MAHRP-1c
binds with a stoichiometry of 1:11. This is consistent with the
increased number of DHGH motifs in the ITG2F6 isoform and
indicates that DHGH is the FP binding motif. Thus, it might be
possible that MAHRP-1 isoforms with an increased number of
repeats might be able tolerate higher concentrations of FP,
although this needs to be tested experimentally. It is interest-
ing to note that HRP2 contains 45 repeats of the tripeptide,
HHA, partly contained within 21 copies of a degenerate repeat
based on AHHAHHAAD and has been shown to bind FP in a
ratio of up to 1:50 (7, 51).
FP has been shown to react with H2O2 to form a ferryl
(Fe(IV)) intermediate that can participate in a number of en-
zyme-like reactions, including a peroxidase-like reaction that
reduces H2O2 at the expense of organic substrates (1). Low
concentrations of H2O2 and other reactive oxygen species may
be present in the host compartment as byproducts of methe-
moglobin formation or hemoglobin denaturation. In this work
we have shown that MAHRP-1 can enhance the peroxidase-like
activity of FP at pH 7.4, the presumed pH of the erythrocyte
cytosol, with an efficiency similar to that for HRP2. These data
suggest that MAHRP-1 could play a role in binding FP and
detoxifying reactive oxygen species in the immediate vicinity of
the Maurer’s clefts.
HRP2 is soluble protein that is mainly located in the eryth-
rocyte cytosol in close proximity to the red blood cell membrane
(8, 12). It is possible that HRP2 acts as a roving scavenger of
free FP moieties, protecting the erythrocyte membrane and
cytoskeletal proteins. The central role of HRP2 in parasite
metabolism has, however, been questioned due to the existence
of a clone (clone 3B-D5) lacking both HRP2 and the related
protein, HRP3. This parasite strain shows no distinct pheno-
type, at least under the low oxygen tensions used for in vitro
culture (52). These data suggest substantial redundancy of the
role(s) played by histidine-rich proteins in the malaria para-
site. With the advent of the malaria genome (53), sequences
encoding a number of histidine-rich proteins have appeared in
the sequence databases. These proteins may contribute to the
scavenging of FP in different compartments. For example,
MAHRP-1, which is confined to the Maurer’s clefts, may play
an important role in protecting the lipids and proteins in this
important secretory organelle. In particular, it is possible that
MAHRP-1 plays a crucial role in protecting cysteine-rich motifs
in PfEMP1 from oxidative damage.
In summary, we have identified and characterized a novel
Maurer’s cleft-associated protein that may be involved in the
formation and/or protection of these important subcellular
structures. For the parasite, this might ensure correct traffick-
ing of proteins to the erythrocyte membrane. Understanding
the processes whereby the parasite modifies its host cell and
protects itself against the stress that derives from hemoglobin
degradation might lead to an improved way to control this
devastating disease.
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Malaria parasites export proteins beyond their own plasma membrane to locations in the red blood cells in
which they reside. Maurer’s clefts are parasite-derived structures within the host cell cytoplasm that are
thought to function as a sorting compartment between the parasite and the erythrocyte membrane. However,
the genesis of this compartment and the signals directing proteins to the Maurer’s clefts are not known. We
have generated Plasmodium falciparum-infected erythrocytes expressing green fluorescent protein (GFP) chi-
meras of a Maurer’s cleft resident protein, the membrane-associated histidine-rich protein 1 (MAHRP1).
Chimeras of full-length MAHRP1 or fragments containing part of the N-terminal domain and the transmem-
brane domain are successfully delivered to Maurer’s clefts. Other fragments remain trapped within the
parasite. Fluorescence photobleaching and time-lapse imaging techniques indicate that MAHRP1-GFP is
initially trafficked to isolated subdomains in the parasitophorous vacuole membrane that appear to represent
nascent Maurer’s clefts. The data suggest that the Maurer’s clefts bud from the parasitophorous vacuole
membrane and diffuse within the erythrocyte cytoplasm before taking up residence at the cell periphery.
Plasmodium falciparum causes one of the most life-threat-
ening infectious diseases of humans. Malaria is estimated to be
responsible for up to 2 million deaths per year (34). The patho-
genesis of the disease is associated with the intraerythrocytic
cycle of the parasite, involving repeated rounds of invasion,
growth, and schizogony. The erythrocyte provides a ready
source of protein building blocks, but this quiescent cell pro-
vides little in the way of cellular architecture, as it possesses no
internal organelles and no protein synthesis or trafficking ma-
chinery. As the parasite develops, it effectively remodels its
adopted home by generating membranous structures outside
its own cell and by implementing a complex and unusual sys-
tem for transporting proteins across the host cell compartment
and to its surface. This has led to particular interest in the
membrane-bound compartments that appear in the red blood
cell (RBC) cytoplasm as the parasite matures.
Once the parasite has invaded a new host cell, it resides
within a parasitophorous vacuole (PV). In the ring stage of
intraerythrocytic growth, electron microscopy studies have re-
vealed finger-like extensions of the PV membrane (5, 11, 43).
These extensions are thought to remain connected to the PV
and to develop to form a tubulovesicular network (TVN). As
the parasite matures, disk-like structures appear at the RBC
periphery, characterized by a translucent lumen and an elec-
tron-dense coat of variable thickness (4, 11, 22). These struc-
tures are referred to as Maurer’s clefts, which is something of
a misnomer, as they do not appear to be formed by invagina-
tion of the RBC membrane (4, 11, 22), though they often
appear to be tethered to the RBC membrane by fibrous con-
nections with the erythrocyte cytoskeleton (7, 22). The origin
of the Maurer’s clefts is not known, and there is currently some
debate as to whether the peripheral Maurer’s clefts are inde-
pendent structures or subdomains of the TVN (24, 30). Recent
studies used fluorescence microscopy of cells labeled with lipid
probes and electron microscopy of serial sections to examine
the structures in the P. falciparum-infected RBC cytoplasm
(43, 45). These authors postulated that Maurer’s clefts and the
TVN form part of a continuous meshwork. However, other
reports using green fluorescent protein (GFP) chimeras of
Maurer’s cleft-associated cargo (21, 46) suggest that Maurer’s
clefts are distinct, independent entities.
An important virulence molecule that is exported to the
RBC membrane, via the Maurer’s clefts, is P. falciparum eryth-
rocyte membrane protein 1 (PfEMP1) (9, 24). PfEMP1 is a
transmembrane protein that is presented at the RBC surface,
where it mediates adhesion of parasitized RBCs to endothelial
cells in various organs (12, 33). The subsequent accumulation
of infected RBCs in the microvasculature is a pivotal event in
the pathogenesis of falciparum malaria (23). Given the pro-
posed role of Maurer’s clefts in PfEMP1 trafficking, it is of
some interest that components of the plasmodial protein traf-
ficking machinery have been reported to be exported to these
structures (1, 3, 16, 38, 44). Moreover, some Maurer’s cleft-
associated proteins, such as the ring exported protein 1 (REX1,
(15) and P. falciparum erythrocyte membrane protein 3
(PfEMP3) (42), show structural similarity to vesicle-tethering
proteins. This suggests that the Maurer’s clefts may function as
a protein-sorting compartment that is exported into the RBC
cytoplasm.
* Corresponding author. Mailing address: Department of Biochem-
istry, La Trobe University, Melbourne 3086, Australia. Phone: 61-3-
94791375. Fax: 61-3-94792467. E-mail: L.Tilley@latrobe.edu.au.
† Supplemental material for this article may be found at http://mcb
.asm.org/.
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A series of integral membrane proteins have been shown to
be resident at the Maurer’s clefts (24). These include P. fal-
ciparum skeleton binding protein 1 (PfSBP1) (7), the Maurer’s
cleft two-transmembrane domain proteins (Pfmc2-tm) (32),
and the subtelomeric variable open reading frame (STEVOR)
proteins (18). Several novel proteins identified by proteomics
analysis (39) are also thought to be Maurer’s cleft associated.
We recently characterized a Maurer’s cleft resident protein
referred to as the membrane-associated histidine-rich protein
1 (MAHRP1) (37). MAHRP1 is a protein with a predicted
molecular mass of 28.9 kDa. The C-terminal domain of
MAHRP1 in 3D7 has a histidine content of almost 30% and
contains six tandem repeats of the amino acid sequence DHGH,
with additional preceding DH repeats.
Recent work (17, 26) has identified a pentameric vacuolar
transit sequence/protein export element (VTS/PEXEL motif)
in the N-terminal region of exported proteins that is required
for transport across the PV membrane. The knob-associated
histidine-rich protein, KAHRP, and many other exported pro-
teins possess a highly conserved VTS/PEXEL motif, while a
related translocation motif appears to be important for traf-
ficking of PfEMP1 across the PV membrane. MAHRP1 does
not contain a sequence that conforms to the criteria used to
define the VTS/PEXEL motif, indicating that this resident
protein may be trafficked to the RBC cytoplasm via a different
route.
Despite the importance of the Maurer’s clefts as an inter-
mediate compartment in the delivery of PfEMP1, little is
known about the molecular processes that generate these
structures and the signals that direct resident proteins to this
compartment. In this study, we have generated P. falciparum
transfectants expressing GFP chimeras of MAHRP1 to dissect
the domains needed for correct trafficking. The data suggest
that MAHRP1 is trafficked through the parasite ER to the PV
membrane. MAHRP1 is then incorporated into small foci
(presumably nascent Maurer’s clefts) that extend from the
PV/TVN prior to transfer to the cell periphery.
MATERIALS AND METHODS
Materials. Rabbit antiserum recognizing GFP and REX1 was kindly donated
by Mike Ryan, La Trobe University, Australia, and Paula Hawthorne, Queens-
land Institute of Medical Research, Australia. Preparation of an antiserum
recognizing the PfEMP1 cytoplasmic domain will be described elsewhere (13).
Mouse anti-MAHRP1 serum was generated as described previously (37). Mouse
antibodies recognizing GFP were obtained from Roche. BODIPY-TR-ceramide
was obtained fromMolecular Probes Pty Ltd. The pARL1a vector was generated
as described previously (10).
Plasmid constructs and transfection of P. falciparum. MAHRP11-249,
MAHRP11-105, MAHRP1106-124, MAHRP1125-249, and MAHRP1106-249 were
cloned into vector pHH2 (31) and then subcloned into pARL1a (10), which had
been modified to contain the GFP coding region and additional cloning sites
(pARL1mGFPmT; kindly generated by A. Adisa, La Trobe University). Briefly,
constructs were PCR amplified using primers (see Table I at http://www.latrobe
.edu.au/biochemistry/labs/tilley/SuppS1T1T2.html) incorporating ApaI and AflII
sites and cloned into the vector pARL1mGFPmT. P. falciparum-infected RBCs
(ring stage, 3D7 strain) were transfected with 100 �g plasmid DNA and cultured
in the presence of 10 nM WR99210, a plasmodial dihydrofolate reductase
inhibitor (31). Parasites expressing the GFP chimeric proteins were obtained 20
to 35 days after transfection and thereafter remained close to 100% positive for
GFP expression when maintained in the presence of 10 nM WR99210.
Western blot analysis of transfectants. Asynchronous P. falciparum-infected
RBCs were purified by magnetic sorting (Miltenyi Biotec). Protein samples were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12.5%
acrylamide), transferred to a nitrocellulose membrane (Hybond-C extra; Amer-
sham Biosciences) for 1.5 h using a Trans-Blot semidry electroblotter (Bio-Rad),
and probed with antiserum followed by alkaline phosphatase-conjugated second-
ary antibodies (Sigma). The membrane was developed in 20 ml of Tris buffer
containing 200 �l of 5-bromo-4-chloro-3-indolyl phosphate (15 mg/ml) and 200
�l of nitroblue tetrazolium (30 mg/ml in 70% dimethylformamide). Antibodies
for immunoblot analyses were used at the following dilutions: mouse anti-
MAHRP1, 1:500; mouse anti-GFP, 1:2,000; goat anti-mouse immunoglobulin G
(IgG), 1:20,000.
Fluorescence microscopy and localization studies using indirect immunoflu-
orescence. Fluorescence microscopy was performed using either an Olympus
BX50 epifluorescence microscope with 4�,6�-diamidino-2-phenylindole, fluores-
cein, and rhodamine filter cubes or an inverted Leica TCS-SP2 confocal micro-
scope using�100 oil immersion objectives (1.4 numerical aperture). In the latter
case, argon ion (488 nm) and helium-neon (543 nm) laser lines were employed
with the appropriate dichroic filters, and emission wavelengths were selected as
previously described (2). Parasitized RBCs expressing MAHRP1-GFP were
mounted wet on a glass slide, covered by a glass coverslip, sealed, and imaged
within 20 min at ambient temperature (maintained at 20°C).
BODIPY-ceramide was used to label parasitized RBCs as described previously
(2). Briefly, parasitized RBCs were resuspended in complete medium (5% par-
asitemia, 10% hematocrit) and incubated in the presence of 1 �M BODIPY-
TR-ceramide at 37°C for 60 min, and then they were washed three times in
complete medium and examined by fluorescence microscopy. Serial optical sec-
tions (�0.1 to 0.2 �m per section) of GFP- and/or BODIPY-labeled cells were
used to generate average maximum-projection three-dimensional (3-D) recon-
structions using either the Leica SP2 imaging software or NIH ImageJ (http://rsb
.info.nih.gov/ij).
For indirect immunofluorescence microscopy, infected RBCs were smeared
onto glass slides and fixed in ice-cold acetone:methanol (1:1, vol/vol) for 10 min.
Slides were probed with one of the following primary and secondary antibodies:
mouse anti-MAHRP-1c (1:100), rabbit anti-PfEMP1 (1:200), rabbit anti-REX1
(1:1,000), rabbit anti-GFP (1:100), fluorescein isothiocyanate-conjugated anti-
rabbit immunoglobin G (IgG; 1:50), and Alexa 568-conjugated anti-mouse IgG
(1:200). The slides were mounted in 90% glycerol containing 0.05% N-propyl
gallate (Sigma) to reduce bleaching.
Electron microscopy. Isolated A4 strain-parasitized RBCs were permeabilized
with saponin (36) and incubated with rotation at 37°C with a 1:100 dilution of
anti-MAHRP1 serum in RPMI medium with protease inhibitors, followed by 5
nm gold-labeled goat anti-mouse IgG (BioCell). Samples were postfixed with 4%
glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.2, treated with osmium
tetroxide, dehydrated, and embedded in epoxy resin. Thin sections were stained
with uranyl acetate and lead citrate before examination in a Joel 1200EX trans-
mission electron microscope.
Fluorescence recovery after photobleaching. The general theory and practice
of photobleaching measurements has been described elsewhere (19). RBC sus-
pensions (�30% hematocrit) were placed under number 1.5 coverslips, sealed
with petroleum jelly, and viewed on an inverted Leica TCS SP2 confocal micro-
scope with a 100� oil immersion objective (1.4 numerical aperture). Images (8
or 12 bit, typically 256 by 256 pixels) were obtained using the 488-nm line of an
argon ion laser, and the fluorescence collected through a long-pass 495-nm filter
before wavelengths of 500 to 560 nm was selected using the instrument’s soft-
ware. To minimize photobleaching during image acquisition and to maximize the
fluorescence signal, the confocal pinhole was opened (3.3 Airy units), the pho-
tomultiplier gain was set to high levels, and the laser intensity was minimized to
achieve less than 2% bleaching per image. A typical photobleaching measure-
ment comprised two prebleach images to assess the degree of bleaching during
image acquisition, a 100- to 1,000-ms spot irradiation of a defined point with the
unattenuated laser, and a series of postbleach images. The first postbleach image
was obtained immediately after the bleach pulse and is defined as postbleach
time zero. Image processing, including background correction, smoothing, and
image analysis were performed as described previously (2).
RESULTS
Full-length MAHRP1-GFP is expressed in transfected P.
falciparum. The MAHRP1 protein sequence (3D7 strain) is
shown in Fig. 1a. Exon 1 of theMAHRP1 gene encodes the first
130 amino acids of the protein, including the 19-amino-acid
transmembrane domain and the beginning of the carboxy-ter-
minal domain. Residues 125 to 249 comprise the histidine-rich
C-terminal domain. We have generated a chimera comprising
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the sequence coding for full-length MAHRP1 linked to the 5�
end of sequence encoding GFP. The full-lengthMAHRP11-249-
GFP chimera was inserted into the transfection vector
pARL1a (10) under the control of the PfCRT 5� region (Fig.
1b). PfCRT 5� is a moderate promoter that drives maximal
expression in the late ring stages (8), which is similar to the
expression profile for MAHRP1 (35).
Asynchronous parasite cultures of parent and transfected
lines were subjected to Western blotting and probed with a
mouse anti-MAHRP1 antiserum (37) and a rabbit antiserum
against GFP. Anti-MAHRP1 recognized a band of approxi-
mately 40 kDa (Fig. 2a) in lysates of parental 3D7-infected
erythrocytes, as reported previously (37), and an additional
band of approximately 70 kDa in the MAHRP11-249-GFP
transfectant (Fig. 2a, arrowhead). The relative intensity of the
upper band indicates that MAHRP1-GFP is expressed at lower
levels than endogenous MAHRP1. When the blotted lysates
were probed with antibodies recognizing GFP, no reactivity
was observed in uninfected RBCs or in the 3D7 parent para-
sites (data not shown), while an approximately 70-kDa protein
was observed in MAHRP11-249-GFP transfectants (Fig. 2b,
right lane). Both endogenous MAHRP1 and MAHRP1-GFP
migrate with slightly higher apparent molecular masses than
predicted (28.9 kDa and 55.9 kDa, respectively). The higher
apparent molecular mass is probably due to charged residues
in the repeat region of the protein which can cause anomalous
migration. There is no evidence for proteolytic processing
of either endogenous MAHRP1 or the MAHRP11-249-GFP
chimera.
The MAHRP11-249-GFP chimera is trafficked to Maurer’s
clefts via subdomains of the PV membrane. Fluorescence mi-
croscopy of live cells has been used to examine the location of
MAHRP11-249-GFP at different stages of growth (Fig. 3). In
early-ring-stage parasites (Fig. 3a and b), the MAHRP1-GFP
chimera is already present in structures in the host cell cyto-
plasm that appear to be Maurer’s clefts (white arrows). In late
ring and early trophozoite stages, some cells showed an accu-
mulation of GFP fluorescence in what appear to be subcom-
partments associated with the PV or PV membrane (Fig. 3b to
d, yellow arrows). In schizont-stage parasites, the structures in
the host cell cytoplasm containing MAHRP1-GFP appear to
be pushed against the host cell membrane (Fig. 3e), and upon
lysis of the host cell membrane (visualized by loss of edge
effects in the differential interference contrast [DIC] image)
during schizont rupture they remain associated with the lysed
RBC membrane (Fig. 3f).
To obtain additional information regarding the organization
of the GFP chimera, we generated a 3-D reconstruction from
a series of confocal optical slices of the transfectants (see Fig.
S2 in the supplemental material for a rotatable image). Dis-
tinct compartments containing the GFP chimera are observed
close to the periphery of the infected RBC and may be phys-
ically tethered to the RBC cytoskeleton (7). In addition, we
observed GFP-containing structures located near the surface
of the parasite that are visualized as bright puncta and more
extended worm-like structures (see Fig. S2 in the supplemental
material). We suggest that these may be protein sorting sites or
subdomains of the PV, or they may represent nascent Maurer’s
clefts forming at the PV membrane.
The relationship between the PV-associated (presumably
nascent) Maurer’s clefts and various membranous structures
in the host cell cytoplasm was examined by colabeling the
MAHRP11-249-GFP transfectants with BODIPY-ceramide.
This lipid label has previously been used to examine the orga-
nization of the PV membrane and TVN (2, 14). Single optical
slices through two dual-labeled trophozoite-stage-infected
FIG. 1. Organization of the MAHRP1 sequence and transfection
construct. (a) P. falciparum 3D7 MAHRP1 amino acid sequence (ac-
cession no. AAQ63567; MAL 13P1.413). The transmembrane domain
and C-terminal histidine-rich repeats are highlighted in boldface and
boldface italics, respectively. The exon boundary site is shown with an
arrowhead. (b) Schematic diagram of the pARL1a vector showing
insertion of the MAHRP1 sequence upstream of the GFP coding re-
gion. The plasmid contains a human dihydrofolate reductase (hDHFR)
selection cassette. CRT, chloroquine resistance transporter; CAM, cal-
modulin; HRP2, histidine-rich protein 2.
FIG. 2. Western blot analysis of parasite proteins showing expres-
sion of MAHRP1-GFP chimeras. (a) P. falciparum parental 3D7-
infected RBCs (�5 � 107 parasites) and MAHRP11-249-GFP transfec-
tants (�108 parasites) were subjected to Western blot analysis and
probed with anti-MAHRP1 mouse serum. Endogenous MAHRP1 is in-
dicated with an arrow. MAHRP11-249-GFP is indicated with an arrow-
head. (b) Total protein extracts from the different transfectants were
subjected to Western blot analysis and probed with anti-GFP antibodies.
The predicted sizes of the fusion proteins are given in Table II at http:
//www.latrobe.edu.au/biochemistry/labs/tilley/SuppS1T1T2.html.
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RBCs are shown in Fig. 4a and b. BODIPY-ceramide labels
the membrane-rich parasite cytoplasm very heavily as well as
punctate structures in the RBC cytoplasm. Most of these struc-
tures are labeled with both BODIPY-ceramide and GFP (Fig. 4a
and b, white and blue arrows) and presumably represent na-
scent and mature Maurer’s clefts. The labeling with BODIPY-
ceramide is fairly weak, which may indicate a relatively low
lipid content. Some BODIPY-ceramide-labeled structures do
not contain MAHRP11-249-GFP (Fig. 4a and b, yellow arrows).
These appear to represent a second population of TVN buds
and extensions that are distinct from the Maurer’s clefts. We
have previously reported the budding of regions of the TVN
(2). Figure 4c shows an average projection of a cell generated
from a series of optical slices. A video showing rotatable im-
ages can be found in Fig. S3 in the supplemental material.
Rotation of this image reveals what appear to be nascent
Maurer’s clefts associated with extensions of the PV mem-
brane or TVN (Fig. 4c, blue arrow). Again, the data suggest
that MAHRP11-249-GFP collects into subdomains on the PV
membrane or TVN.
Immunofluorescence analysis confirms the Maurer’s cleft
location of MAHRP1-GFP. We have used indirect immunoflu-
orescence microscopy to confirm the subcellular location of
MAHRP11-249-GFP in the transfectants. In cells fixed with
acetone:methanol (which destroys the endogenous GFP fluo-
rescence), antibodies against GFP gave a pattern of distribu-
tion similar to that observed in live cells. The chimera was
present in punctate structures in the host cell cytoplasm (Fig.
5a). Dual labeling with an antiserum recognizing endogenous
FIG. 3. Expression of MAHRP11-249-GFP at different stages of the
intraerythrocytic cycle of P. falciparum. The images represent a DIC
image, the GFP fluorescence signal, and an overlay of these images.
Ring and trophozoite stage parasites (a to d) show puncta of fluores-
cence in the RBC cytoplasm which appear to represent peripheral
Maurer’s clefts (white arrows). Some cells (see, e.g., panel c) show a
ring of “beads” of fluorescence around the PV. These foci may repre-
sent nascent Maurer’s clefts (yellow arrows). Mature schizont-stage
parasites (e) show flattening of the peripheral Maurer’s clefts against
the RBC membrane. In a burst schizont (f), the remnant Maurer’s
clefts remain associated with the lysed host cell membrane. Bar, 5 �m.
The intensities of the images were adjusted to optimize the fluores-
cence signal at each parasite stage.
FIG. 4. Dual labeling of MAHRP11-249-GFP transfectants with
BODIPY-ceramide. (a to c) The images represent (from left to right)
a DIC image, GFP fluorescence, BODIPY-ceramide fluorescence, and
an overlay of the GFP (green) and BODIPY-ceramide (red) images.
The parasite membranes are intensely labeled with the lipid probe.
Some extensions of the PV membrane are dotted with foci of
MAHRP1-GFP (white arrows). Some of the BODIPY-labeled struc-
tures (probably TVN extensions and buds) are not labeled with GFP
(yellow arrows), while others (presumably Maurer’s clefts) are labeled
with GFP (blue arrows). The fluorescence images in panel c corre-
spond to an average projection generated from a series of optical
slices. See Fig. S3 in the supplemental material for a video showing a
3-D rotation. Bar, 5 �m.
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MAHRP1 showed a very similar pattern, with almost complete
overlap of GFP and MAHRP1 in the punctate structures in the
RBC cytoplasm (Fig. 5a, white arrow).
To confirm the identity of the punctate compartments in the
host cell cytoplasm, we undertook dual labeling with a known
Maurer’s cleft marker, the ring-stage-exported protein REX1
(Fig. 5b). The complete overlap of these signals (Fig. 5b, white
arrows) provides further evidence that these structures are
Maurer’s clefts. We also examined the profiles of cells labeled
with an antiserum against the cytoadherence antigen, PfEMP1.
This protein is exported to peripheral Maurer’s clefts (Fig. 5c)
prior to redistribution to the RBC membrane (Fig. 5c, blue
arrow). MAHRP1 is colocalized with PfEMP1 when it is asso-
ciated with the Maurer’s clefts (Fig. 5c, white arrow) and may
play an important role in transit of this protein through the
Maurer’s cleft compartment.
Ultrastructural analysis reveals MAHRP1 organization and
orientation at the Maurer’s clefts. To examine the exact loca-
tion of endogenous MAHRP1, we have introduced antibodies
against the C-terminal domain of MAHRP1 into saponin-per-
meabilized infected RBCs using methods developed previously
(36). The permeabilized cells were incubated with 5 nm gold-
labeled anti-mouse IgG prior to processing for transmission
electron microscopy. This allowed us to probe the population
of endogenous MAHRP1 in the RBC cytoplasm compartment.
Maurer’s clefts with electron-dense coats were frequently ob-
served in sections of early trophozoite-stage parasitized RBCs
(Fig. 6). The Maurer’s clefts were decorated with gold particles
that appeared to be concentrated in the central region of the
organelle. The fact that the MAHRP1 antibody (which is
raised against the C-terminal domain) is able to access its
binding epitope in these permeabilized cells and the observa-
tion that the particles are largely arrayed at the cytoplasmic
surface of the Maurer’s clefts indicates that the C terminus
(His-rich region) of MAHRP1 is facing the RBC cytoplasm. In
a few (�10%) of the labeled cells, it was possible to observe
gold particles associated with areas of the PV membrane (Fig.
6b and c, arrowheads). These may represent areas of the PV
membrane where MAHRP1 has accumulated prior to the for-
mation of Maurer’s clefts.
Part of the N-terminal domain and the transmembrane
domain of MAHRP1 are needed for correct trafficking to the
Maurer’s clefts. MAHRP1 does not contain a sequence that
conforms to the criteria used to define the VTS/PEXEL motifs
(17, 26), indicating that this resident protein may be trafficked
to the Maurer’s clefts via a different route to other exported
proteins. Alternatively, MAHRP1 may contain an unusual
VTS/PEXEL motif or a different export signal. In an effort
to determine the regions of the MAHRP1 sequence that are
needed for correct trafficking, we have generated transfectants
expressing a range of fragments of MAHRP1 appended to
GFP and examined their intracellular locations.
When GFP alone is expressed in transfected P. falciparum, it is
present in the parasite cytoplasm (Fig. 7a; see Fig. S1a at http:
//www.latrobe.edu.au/biochemistry/labs/tilley/SuppS1T1T2.html).
When the N-terminal domain of MAHRP1 was fused to GFP,
the chimeric protein appears to remain in the parasite
cytoplasm (Fig. 7b; see Fig. S1b at the website listed earlier in
this paragraph). By contrast, a GFP fusion protein containing
the transmembrane domain of MAHRP1 appeared to enter
the endoplasmic reticulum (ER) and to remain in this
compartment (Fig. 7c; see Fig. S1c at the website listed earlier
in this paragraph). The ER location is indicated by the fact that
the protein is located in a compartment that surrounds the
nucleus (see Fig. S1c at the website listed earlier in this
paragraph). A construct comprising the transmembrane and
C-terminal domains also appears to remain trapped in the ER
(Fig. 7d; see Fig. S1d at the website listed earlier in this
paragraph).
Thus, it appears that the transmembrane domain is needed
for the chimera to enter the ER, the first step of the export
pathway, but that additional sequence is needed for subse-
quent steps. Therefore, we generated a chimera with the first
169 amino acids of MAHRP1 (comprising the N-terminal and
transmembrane domains and the first 45 amino acids of the
C-terminal region) fused to GFP. The fusion protein was suc-
cessfully exported to the RBC cytoplasm (Fig. 7f) and became
associated with the Maurer’s clefts. This indicates that the first
169 amino acids are sufficient for correct trafficking and that
the His-rich repeats (amino acids 170 to 214) are not needed.
A further construct was generated comprising the first 130
amino acids fused to GFP; this is equivalent to the sequence
encoded by exon 1 (i.e., up to the sixth amino acid of the
C-terminal domain). This fusion protein was partly exported to
the RBC cytoplasm and became associated with the Maurer’s
clefts (Fig. 7e, second row); however, the export process ap-
peared to be less efficient. In this transfectant, a build-up of the
fluorescent chimera in what appears to be the ER and struc-
tures associated with the PV membrane was frequently ob-
FIG. 5. Immunofluorescence microscopy of MAHRP11-249-GFP.
(a) Trophozoite-stage-infected RBC labeled with mouse anti-
MAHRP1 antiserum (red) and rabbit anti-GFP antiserum (green). A
dual-labeled Maurer’s cleft (white arrow) is indicated. (b) Trophozoite
stage infected RBC labeled with mouse anti-MAHRP1 (red) and rab-
bit anti-REX1 (green) antisera. (c) Trophozoite stage infected RBCs
labeled with mouse anti-MAHRP1 (red) and rabbit anti-PfEMP1
(green). Overlap of these signals confirms the Maurer’s clefts location
(white arrow). PfEMP1 is also partly located at the RBC membrane
(blue arrow). The bars represent 5 �m.
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served (Fig. 7e, first row). This indicates that information in
the first half of the C-terminal domain (amino acids 131 to
169), while not necessary for export, may facilitate delivery to
the Maurer’s clefts. To assess whether an export signal is
present within the sequence close to the N terminus, we gen-
erated a further chimera with a truncation of the first 51 amino
acids. As shown in Fig. 7g, this chimera is successfully exported
to the Maurer’s clefts with efficiency similar to that of full-
length MAHRP1-GFP (Fig. 7h). This indicates that the second
half of the N-terminal domain contains the signal for transfer
from the parasite’s endomembrane system to the Maurer’s
clefts. It is important to note that endogenous MAHRP1 was
expressed and correctly trafficked to peripheral Maurer’s clefts
in all transfectants (data not shown).
In some (5 to 10% of cells) of the young trophozoite-
stage transfectants expressing the MAHRP1-130-GFP and
MAHRP152-249-GFP constructs, structures were observed that
appeared to be Maurer’s cleft compartments that had budded
from the PV membrane but had not yet become attached to
the RBC membrane. Stills of one of these cells taken at dif-
ferent time points are presented in Fig. 8a. Movies showing the
movement of untethered clefts in this cell and in some other
examples can be found in Fig. S4 of the supplemental material.
The occasional observation of these mobile clefts supports the
FIG. 6. Transmission electron microscopy of immunogold labeling of MAHRP1 in saponin-permeabilized parasitized RBCs. (a to c) Sections
through the periphery of infected RBCs showing labeling of the Maurer’s clefts (arrows) with variable labeling of the PV membrane (PVM;
arrowheads). In most sections (a), the PVM is unlabeled; however, in a few sections (b and c), there is focal labeling. (d to g) Details of Maurer’s
clefts showing that the gold particles are mainly located in the central region (arrows). K, knobs; P, parasite. Bars, 100 nm.
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suggestion that Maurer’s clefts bud from the PV membrane as
preformed structures and then take up residence at the cell
periphery.
To determine whether the correct GFP-MAHRP1 fragment
chimeras were expressed, we performed Western blot analyses
of each of the different transfectants. Total parasite extracts
were blotted and probed with anti-GFP (Fig. 2b). The immu-
noreactive bands have molecular weights that are close to or
(for parasite lines expressing products incorporating the C-
terminal repeats) slightly higher than the predicted molecular
FIG. 7. Dissecting the domains required for correct trafficking of MAHRP1 to the Maurer’s clefts. At the top is a schematic representation of
the MAHRP1 full-length protein with its three domains (N terminal [N-term], transmembrane [TM], and C terminal [C-term]), with numbering
of key amino acids and the GFP. Transfected P. falciparum-expressing GFP linked to different domains of MAHRP1 were examined by confocal
fluorescence microscopy. (a) GFP alone is evenly distributed throughout the parasite cytoplasm. A chimera of the N-terminal region (amino acids
1 to 105) (b) also appears to be restricted to the parasite cytoplasm. Chimeras of the transmembrane domain of MAHRP1 (106 to 124) (c) and
of the transmembrane domain and C-terminal region of MAHRP1 (amino acids 106 to 249) (d) appear to be located in the parasite’s
endomembrane system. A chimera of the N-terminal region and transmembrane domain of MAHRP1 (amino acids 1 to 130) (e) is partly exported
to the RBC cytoplasm but in some cells accumulates within the parasite. A chimera containing amino acids 1 to 169 (f), a deletion of the first 51
amino acids (g), and full-length MAHRP1-GFP (h) are efficiently exported to the RBC cytoplasm. Bars, 5 �m.
FIG. 8. Molecular organization of GFP chimeras in different compartments. (a) Overlay images of a MAHRP11-130-GFP transfectant displaying
mobile Maurer’s clefts taken at consecutive time points. One moving cleft observed over time is indicated with white arrows. A movie of this cell
and other examples can be viewed in Fig. S4. The bar represents 5 �m. (b to d) Photobleach analysis. The panels show the DIC images and the
prebleach (pre) and postbleach (post) fluorescence images at the times (in seconds) indicated. The position of the bleach pulse is indicated by white
arrows. (b) Bleaching of MAHRP152-249-GFP in a tethered peripheral Maurer’s cleft with a 300-ms bleach pulse. There is no recovery of the signal
after photobleaching, indicating a physically separate structure. Bleaching of a PV membrane-associated MAHRP152-249-GFP focal region with
300-ms bleach pulses (c) and a structure in close proximity to the PV membrane with a 200-ms bleach pulse (d). There is no recovery of
fluorescence into the bleached areas. Scale bars, 5 �m.
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weights. Predictions of the expected sizes for each of the fusion
proteins are given in Table II at http://www.latrobe.edu.au
/biochemistry/labs/tilley/SuppS1T1T2.html. In each case a
single band was observed, indicating that there is no proteolytic
processing of the chimeras.
Exported MAHRP1-GFP becomes tightly associated with
the Maurer’s clefts. We performed photobleaching studies
(19) of Maurer’s cleft-associated full-length MAHRP1-GFP
(MAHRP11-249-GFP) and of the chimera with the first 51
amino acids deleted (MAHRP152-249-GFP) to examine the
physical organization of the fusion proteins and the connec-
tivities of the compartments in which they are located. We first
examined whether the population of the fusion proteins asso-
ciated with the Maurer’s cleft is tightly associated with these
structures or rapidly exchanging with a cytoplasmic pool which,
although not readily visible, may be present. Selective bleach-
ing of MAHRP152-249-GFP associated with a tethered cleft at
the periphery of the RBC was achieved with a 0.3-s exposure to
a laser pulse (Fig. 8b, white arrow). There was no recovery of
fluorescence onto the Maurer’s clefts within the time scale exam-
ined. The same result was obtained for full-length MAHRP1-249-
GFP (data not shown). This indicates that the MAHRP1-GFP
fusion proteins are tightly bound at the Maurer’s clefts and
that there is no connectivity between different Maurer’s clefts,
or at least no exchange of the chimeras. The data are consis-
tent with the suggestion that the fusion proteins are embedded
in the Maurer’s cleft membrane and that the Maurer’s clefts
lack a direct physical connection to other membrane-bound
structures.
We also examined the physical organization of the MAHRP1-
GFP fusion proteins within the fluorescent puncta that are
associated with the PV membrane. We bleached compart-
ments that were close to the parasite surface (Fig. 8c, arrow) or
seemed to be in the process of budding from the PVmembrane
(Fig. 8d, arrow). In both cases the bleach profile was restricted
to the region to which the laser pulse was applied, and there
was no fluorescence recovery into the bleached area. This
indicates that even at the PV membrane, the MAHRP1-GFP-
containing compartments are physically separate structures.
The lateral segregation of MAHRP1-GFP molecules into non-
exchanging subdomains of the PV membrane is consistent with
the suggestion that these domains are sites of formation of
Maurer’s clefts.
Taken together with the BODIPY-ceramide dual-labeling
experiments, the movies of untethered clefts, and the fact that
we did not observe any small MAHRP1-containing vesicles in
the RBC cytoplasm, the data for bleaching of the proximal
(presumably nascent) and peripheral (presumably mature)
Maurer’s clefts suggest that these compartments are assembled
at the PV membrane and trafficked as “ready-made” structures
to the periphery of the RBC. However, it remains formally
possible that MAHRP1 is packaged into small vesicles (that
are transient and difficult to observe) that subsequently fuse
with mature clefts.
DISCUSSION
The malaria parasite establishes a novel and unusual secre-
tory pathway in the cytoplasm of its erythrocytic host. Unable
to commandeer any trafficking machinery from its host cell, the
parasite needs to establish both rolling stock and transport
routes for transfer of material across the host cell cytoplasm. A
major feature of the infected RBC cytoplasm is the appearance of
densely coated, saucer-shaped structures, known as Maurer’s
clefts, that are proposed to function as a transit station or sorting
depot for proteins en route to the RBC membrane (9, 24). Be-
cause of their presumed importance in the trafficking of PfEMP1
and other exported proteins, the Maurer’s clefts are currently
being studied in some detail.
MAHRP1 is a Maurer’s cleft resident protein that may be
involved in the formation of this important organelle or in the
transit of PfEMP1 through this compartment (37). It is a small
protein with no significant homology to any known se-
quence. It has no predicted N-terminal signal sequence but
has a 19-amino-acid Phe-rich transmembrane domain. In
this work, we have generated transfected parasites expressing
fusions of either full-length MAHRP1 or a series of MAHRP1
fragments in an effort to dissect the pathway for trafficking to
the Maurer’s clefts. Indeed, full-length MAHRP1-GFP is traf-
ficked to the host cell cytoplasm, where it occupies the same
compartments as endogenous MAHRP1.
We have used saponin permeabilization of infected RBCs as
a means of introducing gold-labeled antibodies that recognize
the C-terminal domain of endogenous MAHRP1. Transmis-
sion electron micrographs of these labeled cells revealed
Maurer’s clefts decorated with gold particles on their cyto-
plasmic surface. This indicates that the C-terminal domain
of MAHRP1 is exposed to the RBC cytoplasm. This is in
agreement with the prediction of the PSORT algorithm (27),
which suggests a type Ib orientation for MAHRP1. Another
Maurer’s cleft resident, PfSBP1, is also predicted to be a type
Ib protein and is known to be oriented with its C-terminal
region facing the RBC cytoplasm (7).
MAHRP1 appears to be concentrated in the central region
of the Maurer’s clefts. Permeabilization of parasitized RBCs
has previously been used to introduce antibodies against the
cytoplasmic domain of PfEMP1 into the host cell cytoplasm.
A similar distribution was observed for PfEMP1, although
PfEMP1 was also observed associated with fibrous extensions
of the Maurer’s clefts (22). It is possible that MAHRP1 plays
a role in docking PfEMP1 complexes onto the Maurer’s cleft
membrane or helping to insert PfEMP1 into a membrane en-
vironment. In contrast, electron microscopy analysis of PfSBP1
revealed preferential labeling of the rims of the Maurer’s clefts
(7). These data suggest that the Maurer’s clefts could contain
subcompartments that perform different functions.
The availability of transfectants expressing MAHRP1-GFP
offers the possibility of following the pathway for trafficking of
this protein and potentially for observing the mode of forma-
tion of Maurer’s clefts. In some transfected cells, we observed
an accumulation of MAHRP1-GFP in foci associated with the
PV membrane, presumably en route to the host cell cytoplasm.
We have used colabeling with BODIPY-ceramide and 3-D image
reconstruction to examine the organization of MAHRP1-GFP
within the PV membrane. The lipid probe labels the endo-
membrane system of the parasite as well as the PV membrane/
TVN extensions and small discrete structures in the host cell
cytoplasm. Some of the membranous structures in the RBC
cytoplasm (presumably the Maurer’s clefts) are labeled with
MAHRP1-GFP, while some are not; these could represent
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regions of the TVN that have budded into the RBC cytoplasm
but are distinct from Maurer’s clefts, as has been reported
previously (2).
We were particularly interested in the foci of MAHRP1-
GFP that appear to accumulate in regions of the PV mem-
brane and in tubulovesicular extensions. These foci are remi-
niscent of ER “exit complexes” (28), and we propose that this
accumulation event represents the genesis of the Maurer’s
clefts. The tendency of MAHRP1-GFP to concentrate into
particular subdomains of the PV/TVN membranes may be due
to self association or to association with other Maurer’s cleft
resident proteins. In some of the transfectants expressing trun-
cated MAHRP1-GFP, we occasionally observed an accumula-
tion of mobile clefts that appeared to have budded from the
PV membrane. These data suggest that clefts that are released
from the PV membrane diffuse within the RBC cytoplasm until
they become tethered to the RBC membrane.
Florescence recovery after photobleaching can be used to
provide information on the organization and dynamics of GFP
chimeras in transfected malaria parasites (2, 19, 46). We have
used confocal microscope-based photobleaching protocols to
probe the physical organization of MAHRP1-GFP en route to
the Maurer’s clefts. MAHRP1 chimeras that are present in the
peripheral Maurer’s clefts or in foci at the PV membrane
appear to represent distinct nonconnected structures. Bleach-
ing of one focal aggregate did not deplete the fluorescence
from other regions, indicating that the proteins are not able to
move laterally within the membrane or that the separate foci
are not connected by a fluid continuum. We have previously
reported that soluble GFP-labeled proteins in the PV lumen
can be restricted to subcompartments within the PV, forming
a so-called necklace of beads around the parasite surface (2,
46). The integral membrane protein, exported protein-1
(Exp1), and early transcribed membrane protein, ETRAMP,
have also been reported to undergo lateral segregation into
different regions of the PV membrane (36). Thus, our current
findings reinforce the idea that the PV contains separate sub-
compartments.
A recent study postulated that Maurer’s clefts and the TVN
form part of a continuous network (45). An earlier immuno-
fluorescence microscopy study employing an antibody against
protein Ag45 also led to the conclusion that Maurer’s clefts are
subcompartments of the TVN (6). Our results indicate that the
peripherally located Maurer’s clefts are not interconnected, or
at least that a physical barrier prevents the diffusion of GFP
chimeras between adjacent Maurer’s clefts. Similarly, we find
no evidence for continuity of the peripheral Maurer’s cleft
structures with the PV membrane. However, the nascent Mau-
rer’s clefts do appear to form subdomains of the PV/TVN
membrane, which is consistent with the interconnected struc-
tures observed by other workers (6, 43). This work therefore
serves to clarify the apparent differences between these differ-
ent studies.
In an effort to determine the domains that are responsible
for correct trafficking of MAHRP1 to the Maurer’s clefts, we
generated transfectants expressing subdomains of MAHRP1
linked to GFP. When the N-terminal domain was used alone,
the chimera remained trapped in the parasite cytoplasm. Con-
structs containing the transmembrane domain, either alone or
combined with the C-terminal domain, entered the ER but
were unable to progress beyond this compartment. By contrast,
a construct comprising the first 130 amino acids of MAHRP1
(N-terminal and transmembrane domains and the first 6 amino
acids of the C-terminal region) was trafficked to the Maurer’s
clefts, albeit with lower efficiency, while a construct with the
first 169 amino acids was trafficked with similar efficiency to the
full-length (amino acids 1 to 249) construct. Similarly, a con-
struct comprising the second half of the N-terminal domain
plus the transmembrane and C-terminal domains (amino acids
52 to 249) was efficiently trafficked to the Maurer’s clefts.
Taken together, these data indicate that the information
required for directing MAHRP1 to its final destination is
contained within the second half of the N-terminal domain
and that the transmembrane domain is required for entry
into the ER.
The sequence information directing MAHRP1 trafficking
appears to be different from that needed for correct export of
STEVOR, another Maurer’s cleft-associated protein (29).
Most exported plasmodial proteins, including the STEVOR
family, are encoded by 2-exon genes and possess both a hydro-
phobic signal sequence, encoded by the first exon, and an
RxLxE/Q sequence, close to the start of the second exon (17,
26). PfEMP1 represents a second class of exported proteins. It
lacks an N-terminal hydrophobic signal sequence, and its
export is thought to be determined by a related sequence,
AKHLLDRLG (26) or FFRWFSEWSE (17), in the N-termi-
nal region of the protein. MAHRP1 has a sequence (compris-
ing amino acids 87 to 99) which has a charge distribution
similar to that of the PfEMP1 VTS/PEXEL. It is possible that
this region represents the signal directing forward transit of
this protein.
Charge differences between the N- and C-terminal regions
are important in determining the topology of integral mem-
brane proteins (40). It is possible that charge differences con-
tribute to the signal information needed for correct MAHRP1
trafficking. The N-terminal domain of MAHRP1 has a theo-
retical pI of 4.73, while the C-terminal domain has a pI of 6.19.
This charge difference is responsible for the type Ib prediction
(C terminus cytoplasmic) using the PSORT algorithm (27).
This charge difference is lower in some of the constructs gen-
erated in this study, but for each of the exported chimeras it is
still sufficient to predict a type Ib orientation. Indeed, a lesser
charge difference may explain why MAHRP11-130-GFP is ex-
ported somewhat less efficiently. Interestingly, PfSBP1, another
integral membrane protein that is directed to the Maurer’s cleft,
has a similar charge differential between the N- and C-terminal
domains.
PfEMP1 is thought to insert into a membrane environment
when it reaches the Maurer’s clefts prior to transit to the RBC
membrane (21). It is interesting to note that while the cyto-
plasmic domains of MAHRP1 and PfSBP1 are relatively basic,
the cytoplasmic domain of PfEMP1 is highly acidic. KAHRP
and PfEMP3 are also transiently associated with the Maurer’s
clefts before redistribution to the cytoplasmic face of the RBC
membrane (42, 46). The regions responsible for Maurer’s cleft
binding in KAHRP and PfEMP3 have been defined (20, 25,
46). For PfEMP3, residues 120 to 500 are sufficient for tight
Maurer’s cleft binding (20); this region has a pI of 9.21.
KAHRP residues 60 to 120, with a pI of 7.07, are sufficient for
weak binding to the Maurer’s clefts (25, 46). However, stronger
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interaction with the cytoplasmic domain of PfEMP1 requires
the 5� and 3� repeat regions (41); the pI for this region of the
protein is 9.64. Positively charged regions in the cytoplasmic
domains of MAHRP1 and PfSBP1 may interact with the highly
acidic cytoplasmic domain of PfEMP1 and facilitate the pro-
cess of insertion of PfEMP1 into the Maurer’s cleft membrane.
It is possible that subsequent charge interactions with proteins
such as KAHRP and PfEMP3 may assist in separating PfEMP1
into a separate compartment within the Maurer’s cleft and
facilitate forward transit of this protein.
Taken together with data from other studies, our work suggests
a possible model for trafficking of proteins to the RBC mem-
brane. Maurer’s cleft resident proteins, such as MAHRP1, are
expressed in the ring stage and are likely to be needed for the
genesis of the parasite’s extracellular secretory pathway. Our cur-
rent data provide evidence that MAHRP1 is directed into the ER
and, somehow, transferred from the parasite plasma membrane
to the PV/TVN membrane. Here, MAHRP1 appears to coalesce
into small foci that may represent nascent Maurer’s clefts. The
Maurer’s clefts appear to bud from the PV/TVN membrane be-
fore docking at sites near the RBC periphery, although it remains
possible that small vesicle-mediated trafficking is also involved.
The insertion of PfEMP1 may take place at either nascent or
peripheral Maurer’s clefts. Electrostatic interactions may facili-
tate the docking and sorting functions within this compartment.
In summary, we have provided the first insights into the
formation of Maurer’s clefts and determined regions of
MAHRP that are needed for trafficking to these important
subcellular structures. Strategies that inhibit the formation of
the Maurer’s clefts or the insertion of proteins into this com-
partment could provide a means of interfering with the display
of virulence epitopes at the surface of infected RBCs.
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ABSTRACT 
During the intraerythrocytic development of Plasmodium falciparum, the parasite modifies 
the host cell surface by exporting proteins that interact with or insert into the erythrocyte 
membrane. These proteins include the principal mediator of cytoadherence, Plasmodium 
falciparum erythrocyte membrane protein 1 (PfEMP1). To implement these changes, the 
parasite establishes a protein trafficking system beyond its own confines. Membrane-bound 
structures called Maurer’s clefts (MC) are an intermediate trafficking compartment for 
proteins that are destined for the host cell membrane. We have used transfection technology 
to disrupt the gene for the MC protein membrane-associated histidine-rich protein 1 
(MAHRP1). MAHRP1 is not essential for parasite viability or Maurer’s cleft formation. In 
the absence of MAHRP1, PfEMP1 accumulates in the parasite and is no longer detectable at 
the Maurer’s clefts or on the red blood cell surface. Maurer’s cleft resident proteins, such as 
skeleton-binding protein-1 and ring exported protein and transit cargo such as the knob-
associated histidine-rich protein are exported normally. In an effort to understand how 
MAHRP1 is trafficked to the Maurer’s clefts, we have dissected the N-terminal region and 
identified a segment of 18 amino acids, containing a motif with some similarity to a protein 
export element, which occurs to be necessary for export. 
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INTRODUCTION 
The apicomplexan parasite Plasmodium falciparum causes the most severe form of human 
malaria. The blood stages are responsible for most of the clinical symptoms of the disease and 
the associated mortality. While most intracellular pathogens interact with an active host cell, 
the malaria parasite develops within a cell that is devoid of all organelles and protein 
trafficking machinery. The parasite resides in a parasitophorous vacuole (PV) encircled by a 
limiting membrane. The parasite modifies its host cell by establishing membranous structures 
in the red blood cell (RBC) cytoplasm. These comprise a tubovesicular network (TVN) 
extending from of the PV membrane (Behari and Haldar, 1994; Elmendorf and Haldar, 1994) 
and disc-shaped structures called Maurer’s clefts (MC) at the RBC periphery (Atkinson et al., 
1988; Elford et al., 1997; Lanzer et al., 2006). In addition the parasite modifies the surface of 
the infected RBC with exported proteins that contribute to the virulence of P. falciparum
(Kyes et al., 2001). A key protein in this process is the variant surface antigen, P. falciparum
erythrocyte membrane protein 1 (PfEMP1), which mediates adherence of infected RBCs to 
the endothelial cells of the host. PfEMP1 is presented at knob-like structures on the RBC 
surface. Its C-terminal domain faces the host cell cytoplasm and interacts with the knob-
associated histidine rich protein (KAHRP, Pologe et al., 1987). 
As mature RBCs lack cellular trafficking machinery, the parasite establishes its own secretory 
system for exporting proteins through the PV membrane and across the host cell cytoplasm. 
The mechanisms and molecular apparatus involved in this process are not completely 
understood. A classical signal sequence is sufficient to direct proteins into the parasite’s 
endoplasmic reticulum (ER) with default release into the PV (Waller et al., 1998; Adisa et al., 
2003). Onward transport across the PV membrane requires an additional signature that was 
recently identified and termed the Plasmodium export element (PEXEL, Marti et al., 2004) or 
host targeting signal (HTS, Hiller et al., 2004).  
A number of exported soluble proteins, such as KAHRP and the P. falciparum erythrocyte 
membrane protein 3 (PfEMP3), transiently associate with the cytosolic surface of the 
Maurer’s clefts before redistribution to their final destinations at the RBC membrane 
(Wickham et al., 2001; Knuepfer et al., 2005b). The integral membrane protein, PfEMP1, also 
accumulates in Maurer’s clefts before transfer to the RBC membrane (Kriek et al., 2003; 
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Knuepfer et al., 2005a). These data suggests that the Maurer’s clefts perform a role as an 
intermediate compartment for proteins en route to the RBC membrane.  
The Maurer’s clefts have a number of resident integral membrane proteins (reviewed in 
Lanzer et al., 2006). These include the membrane-associated histidine-rich protein-1 
(MAHRP1, Spycher et al., 2006), skeleton binding protein-1 (SBP1, Blisnick et al., 2000a; 
Cooke et al., 2006; Maier et al., 2006), the Maurer’s cleft 2 transmembrane proteins (PfMC-
2TM, Sam-Yellowe et al., 2004), the STEVORs (Kaviratne et al., 2002; Przyborski et al., 
2005) and the ring exported proteins REX1 and REX2 (Hawthorne et al., 2004; Spielmann et 
al., 2006). Knock-out of SBP1 prevents export of PfEMP1 to the surface of infected RBCs 
revealing the potential importance of the Maurer’s cleft-resident proteins (Cooke et al., 2006; 
Maier et al., 2006). 
The STEVOR, Rifin and the PfMC-2TM families have a hydrophobic ER entry sequence and 
a HTS/PEXEL motif (Hiller et al., 2004; Marti et al., 2004; Khattab and Klinkert, 2006) and 
presumably transit through the PV membrane by interacting with the same transporter that 
passages soluble cargo. The transmembrane domain of STEVOR-GFP is also needed for final 
sorting to the Maurer's clefts (Przyborski et al., 2005). 
We have previously described the Maurer’s clefts resident protein MAHRP1, which is 
exclusively transcribed in ring-stages (Spycher et al., 2003; Spycher et al., 2006). It is a 
transmembrane protein with a histidine-rich C-terminal domain facing the RBC cytoplasm, 
that may be involved in detoxification of haemoglobin break down products (Spycher et al., 
2003). MAHRP1 contains neither a classical signal sequence nor a PEXEL motif. Analysis of 
a series of green fluorescent protein (GFP)- fusions of MAHRP1 fragments showed that the 
transmembrane domain (TM) directs the protein into the endoplasmatic reticulum (ER), while 
additional as yet unidentified motifs within the N-terminal region are required for 
translocation of the protein to the Maurer’s clefts (Spycher et al., 2006).  
To understand the function of MAHRP1, we have generated deletion mutants of the mahrp1
gene in Plasmodium falciparum (3D7 strain). Maurer’s clefts are still formed in the absence 
of MAHRP1 but the export of PfEMP1 is interrupted at the plasma membrane/PV membrane 
interface. As a consequence, no PfEMP1 is detected on the surface of the infected RBC. By 
contrast, other exported proteins such as KAHRP and PfEMP3 are still correctly trafficked.  
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These data suggest that MAHRP1 plays an essential role in the export of PfEMP1 from the 
parasite to the Maurer’s clefts. In an effort to understand how MAHRP1 is trafficked to the 
Maurer’s clefts, we have dissected the N-terminal region and found a region that harbours a 
motif with some similarity to the PEXEL/HTS motif. 
MATERIAL AND METHODS 
Parasites 
P. falciparum parasites (3D7 strain) were cultured in vitro (Trager and Jenson, 1978) in RPMI
medium supplemented with 0.5% Albumax (Invitrogen) or 4% human serum plus 0.25% 
Albumax. Growth synchronization at the ring stage was achieved by sorbitol lysis (Lambros 
and Vanderberg, 1979).  
Plasmid constructs 
To disrupt the mahrp1 gene in 3D7 parasites, the untranslated regions (UTR) flanking the 
mahrp1 gene were cloned as potential recombination sites into the P. falciparum transfection 
plasmid pHHT-TK (Duraisingh et al., 2002) to get pTK_M1. The 5’UTR of mahrp1 was PCR 
amplified using primers, 5-atatgtattttttactttgtgaag-3 and 5-aacataaaaagaaaaaaaaatattccacg-3, 
and cloned into pHHT-TK upstream of the human dihydrofolate reductase coding sequence 
(hdhfr) using Sac2 and Hpa1 restriction sites. The 3’UTR region of mahrp1 was PCR 
amplified using the primers, 5-aggagaaccatgtgaattccaaaaagc and 5-
gccaaacacttcatgaggagataatg-3, and cloned into pHHT-TK downstream of hdhfr using EcoR1 
and Sfo1 restriction sites. 
To generate MAHRP1-GFP chimeras, the sequence encoding MAHRP1 amino acids 74-169 
or 92-169 was PCR amplified and cloned into pARLmGFPmT (Marti et al., 2004; Spycher et 
al., 2006) upstream of GFP using Afl2 and Apa1 restriction sites to yield plasmids 
pARLM74_169GFP and pARLM92_169GFP. PCR primers used for the 74-169 amino acid 
region were 5-gcccttaagatgcaatttaaggcttctctttctg-3 and 5-cgagggccccatatattctggatcaaaaaatgg-3.  
Primers used for the 92-169 amino acid sequence were 5-gcccttaagatgcaatttaaggcttctctttctg-3 
and 5-cgagggccccatatattctggatcaaaaaatgg-3. 
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P. falciparum transfection
P. falciparum infected red blood cells (ring stage) were transfected by electroporation with 
100 µg of plasmid DNA. Transfected parasites were cultured in the presence of 10 nM 
WR99210, a plasmodial DHFR inhibitor, for 20-30 days until viable parasites were observed 
in Giemsa-stained smears (Crabb and Cowman, 1996; Fidock and Wellems, 1997). For the 
establishment of a MAHRP1-deficient strain, parasites were further selected as described 
(Duraisingh et al., 2002). 
DNA extraction and Southern blotting 
Genomic DNA was prepared by phenol/chloroform extraction of saponin-lysed, proteinase K-
treated parasites as described previously (Beck, 2002). Precipitated genomic DNA was 
resuspended in TE buffer. Genomic DNA (from 3D7 and 3D7�M1 strains) and the pTK-M1 
plasmid were digested with Mlu1 and TspR1, separated on a 0.7% agarose gel and transferred 
to a nylon membrane. Southern blot hybridization was performed using standard procedures 
and hybridization detected by ECL (Amersham). The probe, corresponding to the 3’UTR of 
mahrp1, was PCR amplified from pTK_M1 using the primers 5-aggagaaccatgtgaattccaaaaagc 
and 5-gccaaacacttcatgaggagataatg-3. 
Trypsin cleavage assay 
For trypsin cleavage parasites were synchronized by sorbitol, grown to trophozoite stage, 
harvested by magnet cell sorting (CS columns; Mitenyi Biotec), and treated with either 
TPCK-treated trypsin (Sigma) (1 mg/ml in PBS) or incubated in PBS for 1 h at 37°C. After 
incubation, soy bean trypsin inhibitor (Sigma)(10mg/ml in PBS) was added followed by 
incubation at room temperature for 15 min. Cell pellets were extracted with Triton X-100 
(1%) and subsequently with sodiumdodecylsulfate (SDS, 2%) as described (Baruch et al., 
1996).  
Western Blotting 
Cultures were harvested by magnet cell sorting, washed three times in PBS and taken up in 
SDS sample buffer (Invitrogen). Proteins were separated on a 12.5% acrylamide gel and 
blotting to nitrocellulose was performed according to standard protocols. Antibodies used were 
mouse anti-GFP (1:2000) and rabbit anti-ATS preabsorbed on erythrocyte ghosts (1:1000).
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Immunofluorescence analyses and microscopy 
Thin smears of infected RBCs on glass slides were fixed with acetone: methanol for 10 
minutes at -20oC and optionally permeabilized with 0.1% Triton X-100 for 10-30 minutes 
followed by a washing step. Cells were incubated for 1 hour at room temperature with mouse 
anti-MAHRP1-1c (1: 200), mouse anti-SBP1 (1:200), rabbit anti-REX1 (1:500), mouse anti-
KAHRP (1:100)  or rabbit anti-MAHRP2 (1:250). Slides were washed twice and 
subsequently incubated with goat anti-mouse FITC (1:500, Kierkegaard KPL), goat anti-
mouse cy3 (1:500, Jackson Immunological), goat anti-rabbit cy3 (1:500, Jackson 
Immunological), all in the presence of Hoechst 33256 (1 µg/ml).  
RESULTS 
Disruption of the MAHRP1 locus
MAHRP1 (plasmoDB MAL13P1.413) is a transmembrane protein (see supplementary data 
S1A) that is expressed during ring stages and exported beyond the parasite’s confines into 
parasite-derived structures known as Maurer’s clefts. To determine the function of MAHRP1 
and to better understand the role of Maurer’s clefts in protein export, we disrupted the 
expression of endogenous mahrp1 in P. falciparum 3D7 (Supplementary data S1B). We 
generated the plasmid pTK_M1 containing the hdhfr cassette flanked by mahrp1 5’ and 3’ 
UTRs. Integration of the drug resistance cassette into the mahrp1 locus is expected to disrupt 
the coding region.  
Southern blot analysis of genomic DNA of both wild type (Pf3D7) and transfected parasites 
(Pf3D7�M1) with a labelled 3’UTR PCR product revealed single crossover recombination 
into the mahrp1 locus at the 5’UTR as shown in Figure 1. Western blot analysis using a 
polyclonal mouse serum revealed a band at approximately 29 kDa (corresponding to the 
correct size of MAHRP1) in the parent line (Figure 2, left hand lane).  However MAHRP1 
was not be detected in Pf3D7�M1 transfectants (Figure 2, right hand lane), showing that 
disruption of the mahrp1 locus ablated MAHRP1 expression. 
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Maurer’s clefts are formed in the absence of MAHRP1 
To confirm the absence of MAHRP1 at the cellular level, we performed immunofluorescence 
microscopy on acetone-methanol fixed infected RBCs as shown in Figure 3A. When the 
parent line was probed with mouse anti-MAHRP1 serum, a punctuated pattern was observed 
in the RBC cytoplasm consistent with Maurer’s cleft labelling. No labelling of Maurer’s clefts 
was observed in Pf3D7�M1, confirming the knockdown of the MAHRP1 protein (Figure 3A, 
lower row).  
To determine whether the formation or composition of the Maurer’s clefts was altered in the 
absence of MAHRP1, we looked at three different resident Maurer’s clefts proteins. 
Antibodies against SBP1 (Blisnick et al., 2000b) (Figure 3B) label punctuate structure in both 
the parent line and the Pf3D7�M transfectants showing that both strains still express and 
export SBP1 to the Maurer’s clefts. Similarly, anti-REX 1 (Hawthorne et al., 2004) and 
antiserum against another resident Maurer’s clefts protein, termed MAHRP2 (PF13_0276, 
unpublished data) label Maurer’s clefts in both parasite lines (Figure 3 C,D). These data show 
that the absence of MAHRP1 does not impair export of other selected Maurer’s clefts resident 
proteins and that MAHRP1 is not essential for the formation of Maurer’s clefts. 
In the absence of MAHRP1 the export of PfEMP1 is arrested at the PV or PV 
membrane
 PfEMP1 is trafficked via the Maurer’s clefts to the red blood cell membrane where it is 
inserted, with its variable N-terminal domain exposed at the surface and able to interact with 
host cell ligands. En route PfEMP1 is trafficked through the ER, the plasma membrane, the 
PV membrane and the Maurer’s clefts, however details of mode of trafficking are currently 
debated (Knuepfer et al., 2005a; Marti et al., 2005; Lanzer et al., 2006). To assess whether 
MAHRP1 plays a role in the export of PfEMP1 we compared the immunofluorescence pattern 
obtained using anti-PfEMP1 for the parent line and the MAHRP1 knock-out transfectants 
(Figure 4A). Wild type parasites showed characteristic Maurer’s clefts staining, however 
PfEMP1 was not exported beyond the PV or PV membrane in Pf3D7�M1-infected RBCs. 
This is strong evidence for an important function of MAHRP1 in the trafficking of PfEMP1 
beyond the parasite’s border.  
We also examined other proteins that transiently associate with Maurer’s clefts, such as 
KAHRP and PfEMP3.  KAHRP is present in a rim like fluorescence at the red blood cell 
Chapter 4. MAHRP1 is essential for the trafficking of PfEMP1 
71
membrane in both wild type and Pf3D7�M1 parasites (Figure 4B), consistent with trafficking 
to knob structures under the red blood cell membrane (Pologe et al., 1987). PfEMP3 shows a 
heterogeneous distribution at the host cell membrane (Figure 4C) in both lines. This is 
consistent with previous reports (Pasloske et al., 1993) and shows that this protein is also 
correctly exported to the host cell cytoskeleton. Thus, both KAHRP and PfEMP3 are exported 
independently of MAHRP1. 
We have used trypsin digestion of intact infected RBCs to confirm the effect of MAHRP1 
deletion on PfEMP1 trafficking. In wild type parasites a portion of the PfEMP1 population is 
transported to the RBC surface and can be cleaved with trypsin (Kriek et al., 2003; Maier et 
al., 2006). Western analysis of the trypsin-treated parent line with an antibody recognising the 
conserved C-terminal domain revealed two cleavage products (Figure 5, right hand lane) that 
are not present in untreated cells. By contrast these bands were not present in uninfected 
RBCs (Figure 5, left hand lane) or in RBCs infected with the MAHRP1 knock-out line 
(Figure 5, middle lane). The dramatic effect of MAHRP1 deletion on the export of PfEMP1 
implies that MAHRP1 plays an important role in the translocation of PfEMP1 beyond the PV 
membrane. 
MAHRP1 export sequence 
MAHRP1 has no hydrophobic ER entry signal sequence and no motif that meets the criteria 
specified for a PEXEL/HTS sequence (Marti et al., 2005; Hiller et al., 2004; Sargeant et al., 
2006). We previously generated GFP chimeras of a series of MAHRP1 fragments and used 
them to follow trafficking of this protein to the Maurer’s clefts (Spycher et al., 2006). A 
construct comprising full length MAHRP1 fused to GFP is successfully trafficked to the 
Maurer’s clefts. We showed that information in the second half of the N-terminal domain is 
needed for correct trafficking to the Maurer’s clefts (Spycher et al., 2006). 
Here we have further dissected the N-terminal domain of MAHRP1 by generating 
transfectants expressing amino acids 74-169 and 92-169 of MAHRP1 fused to GFP. These 
transgenes are expressed in the presence of endogenous full-length MAHRP1. Transfected P. 
falciparum were analysed for presence of the GFP-fusion proteins by probing saponin pellets 
with anti-GFP. Chimeric proteins of 39 and 37 kDa, respectively were detected (Figure 6A). 
Fluorescence microscopy of live cells was used to examine the locations of the MAHRP1 
chimeras at the young trophozoite stage and to compare these transfectants with parasites 
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expressing full length MAHRP1-GFP (Figure 7B. top row). Full length MAHRP1-GFP is 
efficiently trafficked to the Maurer’s clefts, however a small amount of the fusion protein is 
dotted around the parasitophorous vacuole (Figure 6B, top row). MAHRP174-169-GFP is partly 
exported to the Maurer’s clefts (Figure 6B, second row), however the export process appeared 
to be less efficient than for the full-length construct. In this transfectant, a build-up of the 
fluorescent chimera in what appears to be the ER and structures associated with the PV 
membrane was frequently observed. Interestingly removal of a further 18 amino acids from 
the N-terminal domain (MAHRP192-169-GFP) resulted in trapping of the fusion protein with 
the parasite confines (Figure 6B, third row). It is excluded from the nucleus (as judged by 
dual labelling with DAPI, data not shown) and the digestive vacuole, which is consistent with 
an ER location. This suggests that amino acids within the residues 74-92 of MAHRP1 contain 
the information for transfer of MAHRP1 from the endomembrane system to the PV and on to 
the Maurer’s clefts. Analyses of the amino acid sequence in this region revealed a pentameric 
sequence motif RxWxE which shows some similarity to the PEXEL/HTS motif R/KxLxE/D. 
DISCUSSION 
P. falciparum replicates asexually in terminally differentiated RBCs that are devoid of any 
organelles. The parasite resides within a parasitophorous vacuole, feeding on haemoglobin, 
and subverting the physiology of the RBC by remodelling the host compartment. To do this 
the parasite establishes an export system for proteins that are involved in nutrient uptake or in 
mediating cytoadherence and antigenic variation.  
A number of proteins destined for the RBC membrane, such as PfEMP1, PfEMP3 and 
KAHRP, are trafficked via the Maurer’s clefts, however the precise role of these organelles as 
an intermediate in the trafficking process is not yet completely understood. MAHRP1 is a 
Maurer’s cleft resident protein and is transcribed exclusively during early parasite stages 
although the protein persists throughout the asexual lifecycle (Spycher et al., 2003). To test 
the functional importance of MAHRP1 we generated a P. falciparum 3D7 strain which is 
deficient in this protein (Pf3D7�M1). We show that the endogenous locus has been disrupted 
by a 5’ single crossover integration of the plasmid (Figure 1). This leads to alteration of the 
endogenous promoter and to an ablation of the protein as judged by Western blot analysis 
(Figure 2). 
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We tested whether the absence of MAHRP1 had an effect on the formation of Maurer’s clefts 
or on the presence of other Maurer’s cleft resident proteins. Immunofluorescence assays 
showed that SBP1, MAHRP2 and REX1 were still present at the Maurer’s clefts. The data 
indicate that the Maurer’s clefts can be assembled in the absence of MAHRP1.  
It is important to note that the four Maurer’s cleft resident proteins, MAHRP1, MAHRP2, 
REX1 and SBP1 have several features in common. They are all expressed very early in the 
intraerythrocytic cycle and none of them has a homolog in other plasmodial species or in 
other organisms. They each possess a single predicted transmembrane domain and no 
predicted N-terminal ER entry signal sequence. It is interesting to note that while the C-
terminal domains of MAHRP1 and SBP1 (which have been shown to face the cytoplasm) are 
quite basic, the luminal domains are more acidic. A similar dichotomy is apparent between 
the N- and C-terminal domains of REX1. By contrast the cytosolic domain of PfEMP1 is 
highly acidic. Finally none of these Maurer’s cleft resident proteins has a recognisable 
PEXEL/HTS motif suggesting that they are trafficked across the PV membrane via a different 
route to proteins such as KAHRP and PfEMP1. Indeed analysis of MAHRP1-GFP 
transfectants suggest that this protein is inserted into nascent Maurer’s clefts as they form 
(Spycher et al., 2006). 
We used immunofluorescence assays to determine whether parasite proteins are still exported 
in the absence of MAHRP1. We found that while the trafficking of proteins that are exported 
to the RBC cytoskeleton, namely KAHRP and PfEMP3, was not affected, PfEMP1 export 
was prevented. In the parent line, PfEMP1 is present in the Maurer’s clefts from the early ring 
stage. However, in the MAHRP1 deficient strain, PfEMP1 was not exported beyond the PV 
membrane. Proteolysis of surface-exposed PfEMP1 confirmed the loss of export of this 
protein in Pf3D7�M1 infected RBCs. These data support the suggestion that different modes 
of transport are employed for soluble cargo and integral membrane proteins. 
It is possible that MAHRP1 acts as chaperone for PfEMP1. RAP1 has been shown to act as an 
escort for the rhoptry protein, RAP2 (Baldi et al., 2000). Alternatively, MAHRP1 may be 
responsible for correct insertion of PfEMP1 into the Maurer’s clefts, for example by 
recognition of the PEXEL/HTS signal motif. Recently, deletion mutants of another Maurer’s 
cleft resident protein, SBP1, have been generated in two separate parasite strains. In both 
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cases the Maurer’s clefts were still formed however the two strains displayed different 
phenotypes with respect to PfEMP1 trafficking. When SBP1 was knocked out in the 3D7 
strain (Cooke et al., 2006) PfEMP1 was still exported to the Maurer’s clefts but was not 
transferred to the infected RBC surface. The ability of infected RBCs to adhere to endothelial 
cell receptors was reduced in these knock-out parasites but was restored by complementation 
with SBP1. By contrast, when SBP1 was knocked out in the CS2 strain (Maier et al., 2006) 
PfEMP1 trafficking was arrested at the PV membrane (Maier et al., 2006). This is similar to 
the phenotype that we report here with the MAHRP1 knockout parasites. 
Taken together these studies indicate that resident Maurer’s cleft proteins play a crucial role 
in the export of PfEMP1 to the membrane of the infected RBC. They may perform important 
structural roles or they may interact with cargo en route to the RBC membrane. It is still a 
matter of some debate how cargo proteins, such as KAHRP and PfEMP1, are trafficked to the 
Maurer’s clefts and then transferred onward to the RBC membrane. Based on 3D 
reconstructions of EM sections, Wickert and colleagues postulated that Maurer’s clefts and 
the PV membrane form a continuous network (Wickert et al., 2004). By contrast, we have 
reported that nascent Maurer’s clefts are formed as sub-compartments of the PV membrane 
but that peripheral Maurer’s clefts are independent structures that have lost their connection to 
the PV membrane (Spycher et al., 2006).  
These conflicting views of the architecture of the Maurer’s clefts lead to different, though not 
necessarily exclusive, models for trafficking of proteins to the Maurer’s clefts. If the Maurer’s 
clefts remain connected to the PV membrane, soluble proteins could diffuse from the PV 
lumen along connecting strands to the Maurer’s cleft lumen and then translocate through 
protein transporters into the RBC cytoplasm. Integral membrane proteins, such as PfEMP1, 
could transfer by lateral diffusion along the connected membrane network from the PV 
membrane to the Maurer’s clefts. If on the other hand the Maurer’s clefts are independent 
structures, soluble proteins could reach the RBC cytoplasm by transiting through exporters 
located in the PV membrane. These proteins would then diffuse across the RBC cytoplasm 
before interacting with the cytoplasmic surface of the Maurer’s clefts and eventually the RBC 
membrane. PfEMP1 could incorporate into nascent Maurer’s clefts before they bud from the 
PV membrane. Alternatively, PfEMP1 could be trafficked across the RBC cytoplasm in 
vesicles or as protein complexes and assemble at the peripheral Maurer’s clefts (for reviews 
see Cooke et al., 2004; Marti et al., 2005; Lanzer et al., 2006). While additional work is 
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needed to distinguish between these different possibilities, it is clear that MAHRP1 and SBP1 
could play roles as accessory proteins at various steps in these processes. 
The signals that direct MAHRP1 and SBP1 to the Maurer’s clefts are also intriguing. Neither 
of these proteins has an N-terminal signal sequence nor a PEXEL/HTS motif (as defined by 
the ExportPred algorithms, Hiller et al., 2004; Marti et al., 2005; Sargeant et al., 2006). We 
previously showed that the transmembrane domain of MAHRP1 is required for entry into the 
ER and that information in the second half of the N-terminal domain is needed for correct 
trafficking to the Maurer’s clefts (Spycher et al., 2006). In an effort to further dissect this 
signal we generated transfectants expressing GFP fused to MAHRP1 fragment commencing 
at either residue 74 or residue 92. MAHRP174-169-GFP was still trafficked to the Maurer’s 
clefts albeit somewhat less efficiently than the full length MAHRP1-GFP chimera. This 
shows that the first 73 amino acids are not essential for export to the Maurer’s clefts. By 
contrast, MAHRP192-169-GFP was trapped within the ER. Therefore, residues 74-91 must 
contain a region that allows trafficking of MAHRP1 to the Maurer’s clefts. Intriguingly a 
pentameric sequence, RxWxE, commencing at residue 87, shows some similarity to the 
PEXEL motif, RxLxE. A large hydrophobic tryptophan replaces the highly conserved smaller 
leucine residue, however the PEXEL recognition machinery appears to be relatively 
promiscuous (Bhattacharjee et al., 2006).  
Whether this motif is indeed responsible for MAHRP1 trafficking to the Maurer’s clefts is the 
subject of ongoing research, although it is interesting to note the presence of a related RxFxE 
motif in the N-terminal domain of SBP1. If these motifs indeed prove to be the PEXEL/HTS 
equivalents for Maurer’s cleft resident proteins, this raises the question: How can the same 
motif direct the export of soluble proteins through a protein exporter and direct a set of 
integral membrane proteins into nascent Maurer’s clefts? 
In conclusion, we have defined a region of 18 amino acids that contains the information for 
transfer of MAHRP1 into nascent Maurer’s clefts, thereby pointing to a common mechanism 
for export of Maurer’s cleft machinery and both soluble and membrane-embedded cargo. We 
have shown that loss of MAHRP1 prevents transfer of PfEMP1 to the Maurer’s clefts 
indicating that it may also perform a chaperone function. Taken together with other recent 
reports, the work presented here shows that Maurer’s cleft resident proteins play a very 
important role in trafficking of PfEMP1 to the RBC surface. An increased understanding of 
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factors that interfere with the formation or function of this compartment may lead to the 
development of novel antimalarial strategies. 
Acknowledgements 
We would like to thank the following colleagues for providing antibodies: Don Gardiner 
(anti-REX1), Catherine Braun-Breton (anti-SBP1) and Anouk Müller (anti-MAHRP2). This 
project was supported by the SBF contract C05.0043 for COST Action 857 and by the 
Australian National Research Council. 
Chapter 4. MAHRP1 is essential for the trafficking of PfEMP1 
77
Figure Legends 
Figure 1. Southern blot analysis of the mahrp1 locus in parent 3D7 and transgenic 
Pf3D7�M1 lines. Genomic DNA and the transfection plasmid pTK_M1 were digested with 
TspR1 and Mlu1 restriction enzymes and probed with a labelled 3’ UTR PCR product. The 
predicted sizes are 5137 bp (plasmid pTK_M1), 3792 bp (wild type 3D7), 5333 bp and 3590 
bp (5’ single crossover integrant Pf3D7�M1). The schematic representation depicts the 
disruption of the endogenous promoter by a 5’ single crossover event. 
Figure 2. Western blot analysis of 3D7 and Pf3D7�M1 infected red blood cells. Saponin 
insoluble material from the wild type and Pf3D7�M1 parasites were subjected to SDS-
PAGE, transferred to nitrocellulose and probed with mouse anti-MAHRP1 antiserum. 
Figure 3. Immunofluorescence microscopy of Maurer’s cleft resident proteins. Smears of 
infected RBCs were fixed with acetone methanol and probed with a series of antibodies 
recognising Maurer’s cleft resident proteins. Each row represents a phase (or DIC) image, a 
DAPI stain of the parasite nuclei, the immunofluorescence signal and an overlay of this image 
with the transmission image. The top row of each panel is wild type 3D7; the second row is 
Pf3D7�M1. A. Membrane associated histidine-rich protein 1 (MAHRP1) B. Skeleton 
binding protein 1 (SBP1). C. Ring-expressed protein 1 (REX1). D. Membrane-associated 
histidine-rich protein 2 (MAHRP2).  Scale bar = 5 µm. 
Figure 4. Immunofluorescence microscopy of exported proteins. Smears of RBCs infected 
with wild type 3D7 (top row) and Pf3D7�M1 (bottom row) were probed with antibodies 
recognising proteins exported to the RBC membrane via the Maurer’s clefts. A. P. falciparum
erythrocyte membrane protein (PfEMP1). B. knob-associated histidine-rich protein 
(KAHRP). C. P. falciparum erythrocyte membrane protein 3 (PfEMP3). Scale bar = 5 µm. 
Figure 5. PfEMP1 is not exposed on the surface of Pf3D7�M1 infected red blood cells. 
Intact erythrocytes infected with parental 3D7, Pf3D7�M1 and uninfected erythrocytes were 
treated with (+) or without (-) trypsin and extracts were analysed by Western blotting with 
rabbit anti-PfEMP1 antibody. Surface exposed PfEMP1 is cleaved. 
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Figure 6. MAHRP1-GFP chimeras revealing the export-mediating sequence of 
MAHRP1. A. Western analysis P. falciparum transfectants expressing MAHRP174-169-GFP 
or MAHRP192-169-GFP, compared with the parent parasite line. Mouse anti-GFP was used to 
probe blots of saponin-lysed infected RBCs. Recombinant GFP is shown for comparison. The 
MAHRP1 amino acid sequence is shown with residues D74 to Q92 underlined, the putative 
PEXEL-like motif in red, the transmembrane domain in a grey box, and the histidine-rich C-
terminal domain indicated in yellow. B. Confocal fluorescence microscopy images of P.
falciparum transfectants GFP linked to different MAHRP1 sequences. Upper panel. Full 
length MAHRP1-GFP chimera is efficiently exported to the Maurer’s clefts. Middle panel. 
MAHRP174-169-GFP is partly exported to the Maurer’s clefts and partly retained within the 
parasite. Lower panel. MAHRP192-169-GFP is located in a compartment that surrounds the 
nucleus consistent with the ER. Scale bar 5 µm. 
Figure S1. Schematic representation of the endogenous mahrp1 locus and disruption by 
single crossover recombination. A. Organisation of the P. falciparum 3D7 mahrp1 gene and 
MAHRP1 protein. Exon 1 (grey) codes for the first 130 amino acids including the predicted 
transmembrane domain. Exon 2 codes for the C-terminal domain (aa 131-249) containing the 
histidine-rich region. B. Protein sequence of MAHRP1. The transmembrane domain (residues 
105-124) is boxed. The 18 amino acid region containing the export signal is marked with 
italics. The putative export signal (RxWxE) is in red and underlined. The intron site is 
denoted by �. C. Schematic representation of the crossover recombination event that 
incorporated the transfection plasmid pTK_M1 into the MAHRP1 locus. TK, thymidine 
kinase; UTR, untranslated region; hDHFR, human dihydrofolate-reductase. 
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Chapter 5   
Discussion 
Malaria is one of the top ranking causes of morbidity and death in the world. The causative 
parasite has a complex life cycle with two different hosts and both intra- and extracellular 
existence. The blood stages of Plasmodium falciparum within the vertebrate host are 
responsible for disease symptoms and pathologies. By exporting proteins to the host cell 
surface, it allows the parasite to cytoadhere to the host endothelium and thus avoids clearance 
by the spleen (Rogerson et al., 1995; Baruch et al., 1997). In addition, it undergoes antigenic 
variation (Su et al., 1995) and alters its surface-exposed antigens in a manner that the immune 
system is subrogated. It is therefore important to understand the mechanisms underlying these 
processes to eventually use the knowledge for innovative interventions. I would like to start 
this section with a summary of my work and then discuss key findings in the context of 
specific aspects.  
Parasites undergo asexual replication in red blood cells (RBC). The red blood cell represents a 
unique choice of host cell. It is a terminally differentiated cell devoid of any eukaryotic 
structures or organelles except for the remaining cell membrane. It has to be assumed that on 
cellular level the parasite undergoes a parasitic relationship in where the host cell has not 
much to offer “except” a hiding niche and a high concentration of hemoglobin. In real-estate 
terms this is comparable with the model that the parasite invades/acquires an empty building 
devoid of any walls (compartmentalization and organelles) and lacking any functional 
infrastructure (biosynthetic machinery and trafficking components). During its processes of 
maturation however, the parasite completely remodels its host cell, and if the real-estate 
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business was to purchase the original building back prior to its lysis, it would encounter a 
totally different interior of the building, where a complete process of refurbishment has 
happened and where the exterior has undergone a total remake. 
These remodelling processes within the host cell are essential for the parasite’s survival and 
mark the beginning of our studies. Our work has its origin in a stage specific cDNA library, 
which was generated by Spielmann and Beck (2000). Their work focused on finding genes, 
which are exclusively transcribed in ring stages and are then switched off in later stages. The 
rational behind this work was the hypothesis that genes, which are switched on early upon 
invasion of the parasite in the RBC are crucial for the successful establishment of the parasite 
in its host cell. The authors found 13 ring-stage specific genes and only 2 had significant 
homology to known genes (Spielmann and Beck, 2000). Among the hypothetical genes two 
histidine-rich proteins were found and termed MAHRP1 and MAHRP2. In our work we have 
aimed at the characterization of MAHRP1 (Spycher et al., 2003; Spycher et al., 2006). 
We investigated the localization of MAHRP1 and found it situated at parasite-induced 
structures termed Maurer’s clefts (MC). These to date still enigmatic vesicle-like structures 
are exported from the parasite into the host cell cytosol and persist until the lysis of the cell. 
In accordance with the hypothesis that genes, switched on early upon invasion are products of 
parasite-induced host modifications, MAHRP1 seems to be part of the early remodelling 
component called Maurer’s clefts (reviewed in Lanzer et al., 2006).  
In our work we had set two main objectives being 1) what is the possible function of 
MAHRP1 and 2) how is it trafficked to the Maurer’s clefts. To investigate the role of the 
abundant histidine-rich repeats, we recombinantly expressed the C-terminus and undertook 
spectrophotometric analyses to study its interaction with ferriprotoporphyrine IX (FP) in vitro.
We found a clear correlation between abundance of repeats and the binding stoichiometry to 
FP. Furthermore we observed an effect on redox properties of FP in its bound state to 
MAHRP1c (Spycher et al., 2003). The functional question was also tackled by generating a 
MAHRP1-deficient strain Pf3D7�M1. We used this transgenic strain to assess the effect of 
MAHRP1 on other cellular markers. We found that the major virulence factor PfEMP1 is no 
more exported beyond the parasite’s confines, whereas other selected proteins at both 
Maurer’s clefts and in the knobs where not affected (see chapter 4). 
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MAHRP1 does not possess any of the known trafficking motifs of P. falciparum. It is thus 
unclear, which part of the protein directs MAHRP1 to the Maurer’s clefts. To address the 
second objective we transfected parasites with truncated, GFP-tagged MAHRP1 fragments. 
Transfectants were analyzed by fluorescence microscopy. We broke the protein down into its 
different domains and combinations thereof, and traced the chimera in the infected 
erythrocytes. We found that the transmembrane domain (TM) is sufficient to guide the protein 
to the secretory pathway i.e. the endoplasmatic reticulum (ER). Additional amino acids from 
the C-terminus did not alter its localisation to the ER, whereas amino acids from the N-
terminus added to the transmembrane domain did support the export of the protein to the MCs 
(Spycher et al., 2006). Within the N-terminus there is an region, which together with the TM 
is sufficient for translocation to the Maurer’s clefts. This N-terminal part bears a motif with 
striking similarity to the PVM translocation motif termed VTS or PEXEL (Hiller et al., 2004; 
Marti et al., 2004). 
Looking at MAHRP1 from the histidine perspective 
In the beginning, prior to any evidence on localisation or function of MAHRP1, the most 
striking feature was its histidine-rich C-terminus containing 6 tandem repeats of the amino 
acid sequence DHGH, with additional preceding DH repeats. We found length 
polymorphisms in the histidine-rich domain within different Plasmodium falciparum strains 
and they varied in the number of DHGH repeats (see chapter 2, figure 2).  This, together with 
the fact that the presence of MAHRP1 is required for the export of PfEMP1 to the host cell 
cytosol, allows to speculate that these repeats serve to interact with PfEMP1 and that 
increasing repeat numbers would allow interaction with more PfEMP1 molecules. 
Consequently, strains with more DHGH repeats would export more PfEMP1 and thus 
cytoadhere better.  
According to algorithms generated by The Institute of Environmental Modelling 
(www.tiem.utk.edu/~gross/bioed/webmodules/aminoacid.htm), the average frequency of 
histidine in vertebrate proteins is 2.9% whereas MAHRP1 has an overall histidine content of 
13.7% and thus is nearly 5 times higher. However, taking into consideration that it is a 
transmembrane protein, the histidine rich C-terminus is exposed to and faces a different 
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compartment than the N-terminus, and therefore will exhibit a domain, which has nearly 30% 
histidines and thus a histidine content ten times higher than average. 
The above average frequency of histidines in MAHRP1 can be assumed to be beneficial to the 
parasite. Histidine-rich proteins have been described in other organisms, too, some of which 
have been mentioned in more detail in the introduction. They have in common a role as co-
ordinating ligand in metalloproteins. In some cases this serves to protect the organisms from 
deleterious effects, whereas in other cases these cations are essentially needed for enzyme 
activity.  
In Plasmodium falciparum several histidine-rich proteins have been described, of which P.
falciparum histidine-rich protein 2 (HRP2) is one of the best characterized. Two different 
studies have investigated the role of HRP2 using recombinant protein or synthetic peptides 
and reproducing possible cellular reactions in vitro (Papalexis et al., 2001; Huy et al., 2003). 
Both studies show that HRP2 can specifically bind heme (FP). FP is released as a result of 
hemoglobin breakdown within the food vacuole and in the RBC cytosol and is toxic due to its 
detergent-like and redox properties. Once FP has been polymerized to �-hematin it is no 
longer toxic. The interaction of FP with HRP2 promotes the formation of �-hematin and it is 
thought that HRP2 acts as a platform for this polymerization. Hemoglobin degradation is an 
important amino acid nutrient source for the parasite once it is in the RBC. A red blood cell 
contains around 350 mg/ml hemoglobin, which equates to a concentration of FP of about 20 
mM (Hellerstein et al., 1970). P. falciparum degrades at least 75% of the hemoglobin (Loria 
et al., 1999) and therefore needs to have a mechanisms to reduce subsequent FP levels. HRP2 
is a soluble protein found in both red blood cell cytosol and the food vacuole, where most of 
the �-hematin is stored as “malaria pigment”. HRP2 seems to be a rather widely distributed 
protein, whereas KAHRP, another plasmodial histidine-rich protein appears to have a more 
defined localisation. It is a soluble protein exported to the cytosolic side of the red blood cell 
membrane where it is located at the knobs (Culvenor et al., 1987; Pologe et al., 1987) and is 
essential for knob formation (Crabb et al., 1997). There it acts as part of the  “anchoring 
platform” and has been shown to interact with spectrin and PfEMP1 (Kilejian et al., 1991; 
Waller et al., 1999). To our knowledge no FP-binding studies have been undertaken with 
histidine-rich parts of the KAHRP protein sequence. However, it is likely that histidines from 
KAHRP can also interact with heme and might also have a detoxifiying role. Given its 
location at the knobs, where the major virulence factor is anchored, such a protective role 
becomes even more apparent.  
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We have recombinantly expressed the histidine-rich domain of MAHRP1 (MAHRP1c) and 
shown that it specifically interacts with FP in vitro (Spycher et al., 2003). Furthermore we 
have analyzed properties of FP in its bound state with MAHRP1c and found it to be 10-fold 
more susceptible to degradation by H2O2 than in its unbound state. This fast degradation in a 
bound state seems beneficial to the parasite as it reduces innocuous effects of FP. 
Transmission electron micrographs with antibodies against MAHRP1c revealed MCs 
decorated with gold particles on their cytoplasmic side. This is in agreement with the 
prediction of the PSORT algorithm that suggests a type 1b orientation i.e. the histidine-rich 
domain facing the erythrocyte cytoplasm. Given its location and orientation at the Maurer’s 
clefts and its detoxifying effects on FP, we consider the possibility that MAHRP1 plays a role 
in protecting Maurer’s clefts-associated proteins from deleterious effects of FP. Our in vitro 
experiments however, represent a very limited part of highly complex set of metabolic and 
chemical reactions taking part in vivo. This certainly has to be taken into consideration when 
interpreting these obtained in vitro data.  
The detoxifying role of MAHRP1 could be tested by other means. As we have demonstrated, 
the presence of MAHRP1c significantly enhances the oxidative destruction of FP by H2O2. In 
contrast, chloroquine is an efficient inhibitor of the oxidative destruction of FP by reaction 
with H2O2 (Loria et al., 1999). It would be interesting to compare the IC50 of chloroquine in 
Pf3D7�M1 and wildtype Pf3D7 parasites. We hypothesize a higher IC50 for the wildtype than 
for the Pf3D7�M1, because of the absence of the degradation enhancing effect of MAHRP1 
on FP. 
Because these two strains only differ within the mahrp1 locus, any difference in drug 
toleration observed could be attributed to the absence of MAHRP1. To confirm that the effect 
is due to absence of MAHRP1, the Pf3D7�M1 could then be complemented with a plasmid 
carrying mahrp1 driven by the endogenous promotor, which should reconstitute the wildtype 
IC50.
If no difference in IC50 would be observed, then it would be worthwhile to undertake a 
transcriptional analysis to test if any other histidine-rich protein, including MAHRP2, is 
upregulated to compensate for the missing MAHRP1. However, it is also possible that the 
observed FP binding of MAHRP1 is an insignificant side effect of its yet unknown function. 
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Shedding light “into” Maurer’s clefts 
We have transfected Pf3D7 with a MAHRP1 full-length protein fused to GFP (Spycher et al., 
2006). This fusion protein was successfully exported to the Maurer’s clefts. To our 
knowledge this is the first transgenic strain expressing an exported full length transmembrane 
protein fused to GFP. We used fluorescent microscopy of live cells to examine the location of 
MAHRP1FL-GFP at different stages of the intraerythrocytic cycle. We found MAHRP1 in the 
erythrocyte cytosol in a punctuated pattern consistent with being Maurer’s clefts (MC), in 
young parasites already. As the parasite grows, these dots are less spread out as the host cell’s 
cytosolic space becomes more narrow and the Maurer’s clefts move closer to the RBC plasma 
membrane. Some cells showed accumulation of GFP fluorescence in what appeared to be 
subcompartments associated with the parasitophorous vacuole (PV) or PV membrane. This 
“necklace of beads” was not observed in immunofluorescence assays when probing with anti-
MAHRP1 and might represent a decelerated export due to over expression of the chimeric 
protein. 
We used fluorescence recovery after photobleaching (FRAP) to investigate if these 
subcompartments are independent structures. We monitored the fluorescence over minutes 
and found no diffusion of fluorescence into the bleached area. This finding indicates that 
these subcompartments are independent entities as there is no (lateral) diffusion of fluorescent 
molecules back into the bleached area. Our interpretation of these data is that the Maurer’s 
clefts proteins assemble in what appear to be subcompartments in the PV/PVM prior to exit 
into the erythrocyte cytosol. These findings are consistent with previous reports showing that 
there is no random distribution of integral membrane proteins within the PVM (Spielmann et 
al., 2006). These authors showed that different PVM proteins such as ETRAMPs and EXP1 
define distinct areas and form a mosaic of different microdomains. Such microdomains could 
represent areas that compartmentalize different processes or serve as seeds to initiate 
structures such as the tubovesicular network, the cytostome, or nascent Maurer’s clefts. 
Furthermore, they could serve to generate local polarization in this compartment, which could 
be needed for selection and sorting of proteins during the trafficking process.  
There is an ongoing debate on whether MCs are independent structures or extensions of the 
tubovesicular network and thus in connection with the PVM (Lanzer et al., 2006). This debate 
gave rise to different models on how proteins are trafficked to the erythrocyte membrane. We 
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used FRAP to asses the connectivity of Maurer’s clefts. Our data suggest that MCs are 
independent structures and are not connected to the PVM. This is in contrast to a previous 
study by Wickert et al., in which they three dimensionally reconstructed EM sections of 
Maurer’s clefts (Wickert et al., 2004) and postulated that all membrane profiles observed 
within the infected erythrocyte form a continuous membrane network extending from the 
PVM. They used the strains HB3 and Dd2 whereas we have used 3D7 parasites, but it is 
unlikely that different plasmodium strains would possess two completely different trafficking 
mechanisms. Therefore, further evidence is needed to fully clarify this point. 
We have used MAHRP1FL-GFP parasites to do three-dimensional reconstructions of live- 
imaged infected red blood cells (iRBC). By pre-incubating iRBCS with Bodipy ceramide, a 
lipid stain, we were able to get a better spatial representation of compartments. We observed 
two different populations of Maurer’s clefts: some were located in close proximity to the 
PVM, whereas others were situated towards the periphery of the erythrocyte cytosol. It still 
remains to be shown, if these two populations represent early and late MCs, or if these are 
two different populations persisting at two different locations. These experiments should be 
followed up using additional cellular markers and doing single cell time course analyses. With 
further technical advances, more information will be obtained on vicinity, connectivity, and 
timing of these structures.  
It is important to get a more refined understanding of the Maurer’s clefts. These organelles 
seem to be unique to P. falciparum and as an extracellular trafficking intermediate represent a 
new paradigm in cell biology. They act as trafficking compartment for major virulence factors 
and might represent the heel of Achilles and thus an intervention target. 
Tackling the trafficking of MAHRP1 
P. falciparum modifies its host cell by exporting own proteins into the cytoplasm and to the 
plasma membrane of the erythrocyte. Thereby it establishes immune evasion mechanisms and 
creates new permeation pathways for nutrient uptake. To transfer these proteins, the parasite 
must establish a protein trafficking system beyond the bounds of its own plasma membrane, 
because the erythrocyte lacks a secretory apparatus and hence cannot contribute to it. Because 
the parasite-induced secretory pathway is of great importance for the parasite survival, it 
represents an interesting target for drug intervention. In our work we have investigated the 
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export of MAHRP1 to the Maurer’s clefts. Findings, which are relevant for our work, and our 
own findings are summarized schematically in figure 1 of this chapter. 
In eukaryotic cells, soluble and membrane proteins destined for export are directed into the 
endoplasmatic reticulum by recognition of a classical signal sequence. In the ER proteins 
undergo a “checkup” by the quality control machinery consisting of chaperones and 
associated factors. Additional protein targeting motifs then provide the information for 
subsequent targeting via the Golgi to secretory destinations. The ER thus represents the 
gateway to the secretory pathway. 
In P. falciparum not much is known about the export mechanism and it appears unique 
because the parasite not only exports proteins beyond its plasma membrane into the PV 
(which would be equivalent with secretion in secretory cells), but it also directs and controls 
trafficking through the PVM, into the host cell cytosol, as far as the distal erythrocyte 
membrane. Recent identification of a host cell-targeting signal (PEXEL/VTS) in exported P. 
falciparum proteins has contributed to the understanding of extracellular trafficking (Hiller et 
al., 2004; Marti et al., 2004). It consists of a pentameric sequence, R/KxLxQ/E, and is thought 
to act as PVM translocation signal (Hiller et al., 2004; Marti et al., 2004). When the motif is 
partially or completely mutated, the protein is retained in the PV (Figure 1A). The presence of 
a PEXEL motif encoded close to the start of exon 2 and a first exon encoding a signal 
sequence were used as parameters to predict the plasmodial exportome in silico.
Approximately 400 plasmodial proteins were found (~8% of its proteome) and they appear to 
be unique to Plasmodium because most show no sequence homology to known protein 
domains (Hiller et al., 2004; Marti et al., 2004). Two findings in these two studies are 
particularly noteworthy: 
(i) The translocation motif is present in both soluble and in membrane bound 
proteins. If exported proteins first transit through the secretory pathway of the 
parasite, soluble proteins will be released from the parasite cell surface into the 
lumen of the PV, whereas transmembrane proteins will end up on the parasite 
plasma membrane. If the same signal is used to target both types of protein into the 
erythrocyte, it must be present on the extracellular domain of all exported 
membrane proteins in order to be recognized by a putative receptor on the PV 
membrane. This raises the possibility that transmembrane proteins might be 
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present as protein complexes in the PV instead of being inserted in the plasma 
membrane. The nature of the translocon/channel in the PVM is however not 
known. 
(ii) For PfEMP1, two different export motifs where found by two independent groups. 
Marti et al. describe it to be KxLxD in the N-terminus preceding the first DBL 
domain, whereas Hiller et al. describe it to be QFFRWFSEWSE within the DBL1 
domain.  Interestingly, PfEMP1 is a transmembrane protein and does not contain a 
signal sequence. Marti et al show that the TM directs it to the PV. 
MAHRP1 has no predicted N-terminal signal peptide, which directs it to the ER and lacks a 
PEXEL motif, for translocation through the PVM. Nevertheless, we have shown by 
immunofluorescence experiments that MAHRP1 is present at Maurer’s clefts. With the 
current knowledge it is thus unclear how MAHRP1 is exported. To address this question of 
MAHRP1 trafficking, we have transfected parasites with plasmids containing fusions of 
different MAHRP1 domains with GFP. 
We found that the transmembrane domain (TM) in presence or absence of the C-terminus 
directs MAHRP1 to the ER where it is exclusively visible as a perinuclear fluorescence 
pattern. No fluorescence is seen downstream of the export pathway indicating that the TM 
acts as an ER entry signal of the protein, which is then retained. This is in contrast to previous 
findings where it was shown that ER signal sequence solely fused to GFP directs the protein 
via the ER to the PV, which would be the default secretory destination for plasmodial proteins 
containing only a signal sequence (Adisa et al., 2003). Transmembrane domains and ER-entry 
signal sequences have in common an approximately 20 amino acid hydrophobic core and this 
could explain its direction to the ER, as thought for PfEMP1, but does not explain the 
retention of this construct. Further constructs comprising partial N-terminal deletions fused to 
the GFP-tagged TM were investigated. We found that the truncation of 18 amino acids from 
residues 74 to 92 led to ablation of export and retention of the chimera in the ER.  This stretch 
is located 13 amino acids upstream of the TM and contains a motif RxWxE with limited 
similarity to the PEXEL motif. If this PEXEL-like motif would be responsible for the 
translocation from PV through the PVM it is still unclear which information directs the 
chimera from the ER into the PV. It is conceivable that this short stretch of 18 amino acids 
not only contains a PEXEL-like translocation motif but also the information to direct 
MAHRP1 from the ER to the PV, therefore harbouring a bi-partite signal sequence. 
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Alternatively, the 18 amino acid region contains one signal, which directs it all the way from 
the ER to the Maurer’s clefts. 
However, it seems more likely that as suggested for PfEMP1, the transmembrane domain acts 
as a secretion signal and that our previous constructs, which are retained in the ER might be a 
result of retention by the quality control machinery due to some unusual conformation of the 
fusion protein. 
Additional experiments need to be done to consolidate our evidence. In order to prove that the 
18 amino acids are responsible for export and PVM translocation, it would be worthwhile to 
fuse them to a non-exported transmembrane protein. We have planned now to use ETRAMP4 
(PFD1120c), which would be an ideal candidate as it is an integral membrane protein of the 
PVM (Spielmann et al., 2006). If this chimera is successfully exported, then a further 
narrowing of the sequence should be attempted. Once the minimal sequence requirements are 
identified, site-directed mutagenesis could provide further evidence for abrogation of its 
functionality. If these experiments reveal a novel motif, though PEXEL-like, this would raise 
questions to its function or need. It is thinkable that P. falciparum possesses several different 
export pathways.  
MAHRP1 is not the only exported protein without a signal sequence and without a PEXEL 
motif. Interestingly, there are at least 3 other Maurer’s clefts residents which share these 
similar features with MAHRP1 and are all ring-stage expressed: SBP1 (Blisnick et al., 2000), 
REX1 (Hawthorne et al., 2004) and MAHRP2 (unpublished, PF13_0276). Unfortunately none 
of them has been further investigated in trafficking studies. 
We have generated a MAHRP1-deficient parasite strain to investigate its phenotype. We 
found that in the absence of MAHRP1 Maurer’s clefts are still formed, as selected Maurer’s 
clefts markers MAHRP2, REX1, and SBP1 are still present at the clefts. We further tested for 
the presence of PEXEL-containing exported proteins KAHRP and PfEMP3 and found that 
their trafficking to the RBC membrane was not impaired. In contrast, PfEMP1 is no longer 
exported but is thus retained in what seems to be the PV/PVM. These findings indicate that 
MAHRP1 plays a role in the translocation of PfEMP1 through the PVM (Figure 1B/C). It is 
conceivable that MAHRP1 and PfEMP1 associate in microdomains of the PV/PVM and that 
MAHRP1 acts as an escorter protein for PfEMP1. In a recent study, Maier et al. (2006) have 
generated a SBP1 knockout and made a similar finding. One can speculate that both Maurer’s 
clefts proteins gather in the same microdomains and that both SBP1 and MAHRP1 play an 
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essential role in the translocation of PfEMP1 through the PVM.  It would be interesting to see 
if this dependency between PfEMP1 and MAHRP1 is mutual. This could be tested by 
performing immunofluorescence assays with MAHRP1 antibodies on PfEMP1 knockdown 
parasites (Voss et al., 2006). Furthermore, the presence of additional exported proteins should 
be investigated to see if also soluble proteins are translocated MAHRP1-dependently. 
The inability of PfEMP1 to be exported in the Pf3D7�M1 raises questions as to the nature of 
the interaction of PfEMP1 with MAHRP1. Pf3D7�M1 represents a good platform tool to 
address this question. The strain could be transfected with plasmids containing partial 
domains of MAHRP1 in order to test which reconstitution enables export of PfEMP1. 
Crosslinking experiments and co-precipitation might identify other interacting proteins. 
In this work we have attempted to characterize MAHRP1. By deciphering its amino acid 
sequence in biochemical and protein trafficking aspects we have obtained important 
information for MAHRP1, which represents in many aspects a unique protein. 
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Figure 1. Schematic representation of 3 different export-pathway models and their 
targeting sequences in Plasmodium falciparum. This figure summarizes findings of two 
recent publications (Hiller et al., 2004; Marti et al., 2004) in A and B, and outlines findings on 
the export pathway for MAHRP1 in C. The figure places emphasis on trafficking 
determinants, which have been investigated using green fluorescent protein (GFP)-tagged 
chimera and proposes a novel interaction between the export pathway of PfEMP1 and 
MAHRP1.  
(A) Soluble and membrane proteins destined for export are directed to the endoplasmatic 
reticulum (ER) by recognition of a classical signal sequence or recessed N-terminal signal 
sequence. Proteins most probably pass through a rudimentary Golgi (not shown) en route to 
the parasitophorous vacuole (PV), while recognition of a translocation motif (PEXEL) 
downstream of the signal sequence results in the translocation of proteins such as KAHRP, 
HRP2, and PfEMP3 across the PV membrane via a putative transporter (PT). The exported 
proteins diffuse across the erythrocyte and may interact with the Maurer’s clefts (MC) and 
with the erythrocyte cytoskeleton. Some proteins are diverted from the ER or Golgi to 
intracellular organelles such as the food vacuole and the apicoplast or to regulated secretory 
compartments such as the rhoptries (all not shown).  
(B) The exported integral membrane protein PfEMP1 has a PEXEL motif but does not have a 
signal sequence. The transmembrane domain appears to act as a start transfer signal for 
insertion into the ER and the protein is then transferred to the PV. It is then translocated 
across the PVM in a MAHRP1 dependant fashion, shown as a dotted circle. It is then 
transferred to the MC, which represents an intermediate compartment prior to insertion into 
the red blood cell membrane at the knobs. 
(C) The transmembrane domain of MAHRP1 directs it to the ER. Additional amino acids 
from the N-terminus are required for its export to the Maurer’s clefts via the PV and through 
the PVM. We propose that MAHRP1 and PfEMP1 interact in the PV/PVM and that 
MAHRP1 is essential for translocation of PfEMP1 through the PVM. 
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